Rockwell Medical Inc
Buy, Hold or Sell?

Let's analyse Rockwell Medical Inc together

Penke I guess you are interested in Rockwell Medical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Rockwell Medical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Rockwell Medical Inc

I send you an email if I find something interesting about Rockwell Medical Inc.

Quick analysis of Rockwell Medical Inc (30 sec.)

What can you expect buying and holding a share of Rockwell Medical Inc? (30 sec.)

How much money do you get?

$0.00

When do you have the money?

1 year

How often do you get paid?

10.0%

What is your share worth?

Current worth

$0.73

Expected worth in 1 year

$0.97

How sure are you?

22.5%

+ What do you gain per year?

Total Gains per Share

$0.24

Return On Investment

16.8%

For what price can you sell your share?

Current Price per Share

$1.46

Expected price per share

$1.35 - $2.07

How sure are you?

50%

1. Valuation of Rockwell Medical Inc (5 min.)

Live pricePrice per Share (EOD)

$1.46

Book Value per Share

$0.73

Intrinsic Value Per Share

$-0.81 - $11.03

Total Value Per Share

$-0.09 - $11.76

My calculation of the intrinsic value of Rockwell Medical Inc is based how much money is coming from the company's main activities (Free Cash Flow).

The following numbers are based on moving averages and per share and per quarter.
I use a 6% discount rate for the low estimation and 3% for the high estimation.
The current Free Cash Flow Per Share is 10Y: ($-0.16) 3Y: ($-0.15) TTM: ($-0.08)
The change per quarter (trend) of the Free Cash Flow Per Share is 10Y: ($0.01) 3Y: ($0.02) TTM: ($0.01)

Years	Total Low est.	Total High est.	Added Free Cash Flow
1	$-0.54	$-0.37	$-0.52 - $-0.23
2	$-0.94	$-0.36	$-0.40 - $0.16
3	$-1.23	$0.01	$-0.29 - $0.55
4	$-1.41	$0.72	$-0.18 - $0.94
5	$-1.50	$1.75	$-0.07 - $1.33
6	$-1.50	$3.08	$0.04 - $1.72
7	$-1.42	$4.69	$0.16 - $2.10
8	$-1.27	$6.56	$0.27 - $2.49
9	$-1.07	$8.68	$0.38 - $2.88
10	$-0.81	$11.03	$0.49 - $3.27

2. Growth of Rockwell Medical Inc (5 min.)

Is Rockwell Medical Inc growing?

	Current year	Previous year	Grow	Grow %
How rich?	$21.2m	$13.2m	$2.9m	18.4%

How much money is Rockwell Medical Inc making?

	Current year	Previous year	Grow	Grow %
Making money	-$2.2m	-$5.4m	$3.1m	138.5%
Net Profit Margin	-11.4%	-31.7%	-	-

How much money comes from the company's main activities?

Quarterly Yearly

3. Financial Health of Rockwell Medical Inc (5 min.)

What can you expect buying and holding a share of Rockwell Medical Inc? (5 min.)

Welcome investor! Rockwell Medical Inc's management wants to use your money to grow the business. In return you get a share of Rockwell Medical Inc.

What can you expect buying and holding a share of Rockwell Medical Inc?

First you should know what it really means to hold a share of Rockwell Medical Inc. And how you can make/lose money.

Speculation

The Price per Share of Rockwell Medical Inc is $1.455. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

The fundamentals: the financial health trends of Rockwell Medical Inc.
The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rockwell Medical Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.73. Based on the TTM, the Book Value Change Per Share is $0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $0.11 per quarter.
You may receive quarterly/yearly dividend in the form of additional shares.
You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.

Based on historical numbers we can estimate the returns while holding a share of Rockwell Medical Inc.

How much money are you going to get?

	MRQ		TTM		YOY		5Y		10Y
	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share	$	% of Price per Share
Usd Eps	-0.05	-3.5%	-0.07	-4.9%	-0.16	-10.9%	-0.20	-13.9%	-0.20	-13.6%
Usd Book Value Change Per Share	-0.01	-0.5%	0.06	4.2%	0.11	7.8%	-0.01	-0.7%	0.02	1.2%
Usd Dividend Per Share	0.00	0.0%	0.00	0.0%	0.01	0.6%	0.11	7.6%	0.06	3.8%
Usd Total Gains Per Share	-0.01	-0.5%	0.06	4.2%	0.12	8.4%	0.10	6.9%	0.07	5.0%
Usd Price Per Share	1.89	-	2.81	-	1.02	-	1.92	-	5.02	-
Price to Earnings Ratio	-9.17	-	-9.25	-	-1.96	-	-3.31	-	-8.36	-
Price-to-Total Gains Ratio	-244.24	-	-81.56	-	-4.27	-	-18.55	-	-77.41	-
Price to Book Ratio	2.60	-	6.62	-	2.96	-	4.20	-	-1.86	-
Price-to-Total Gains Ratio	-244.24	-	-81.56	-	-4.27	-	-18.55	-	-77.41	-

When do you get the money?

Usd Investment	$.00
Usd Price Per Share	1.455
Number of shares	687

Gains per Quarter	Trailing 12 Months	5 Year
Usd Dividend Per Share	0.00	0.11
Usd Book Value Change Per Share	0.06	-0.01
Usd Total Gains Per Share	0.06	0.10
Gains per Quarter (687 shares)	42.07	69.04
Gains per Year (687 shares)	168.27	276.17

Years	Return on Investment (TTM)			Return on Investment (5Y)
	Dividend	Book Value gain	Total gains	Dividend	Book Value gain	Total gains
Broker costs	-	-	-10	-	-	-10
1	0	168	158	304	-28	266
2	0	337	326	608	-56	542
3	0	505	494	913	-84	818
4	0	673	662	1217	-112	1094
5	0	841	830	1521	-140	1370
6	0	1010	998	1825	-168	1646
7	0	1178	1166	2129	-196	1922
8	0	1346	1334	2434	-224	2198
9	0	1514	1502	2738	-252	2474
10	0	1683	1670	3042	-280	2750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %

	Trailing 12 Months				3Y				5 Year				10 Year				ALLTIME
				%				%				%				%				%
Earnings Per Share	0.0	4.0	0.0	0.0%	0.0	12.0	0.0	0.0%	0.0	20.0	0.0	0.0%	0.0	40.0	0.0	0.0%	10.0	95.0	0.0	9.5%
Book Value Change Per Share	1.0	3.0	0.0	25.0%	3.0	9.0	0.0	25.0%	6.0	14.0	0.0	30.0%	8.0	32.0	0.0	20.0%	31.0	72.0	2.0	29.5%
Dividend per Share	0.0	0.0	4.0	0.0%	2.0	0.0	10.0	16.7%	4.0	0.0	16.0	20.0%	4.0	0.0	36.0	10.0%	4.0	0.0	101.0	3.8%
Total Gains per Share	1.0	3.0	0.0	25.0%	3.0	9.0	0.0	25.0%	7.0	13.0	0.0	35.0%	9.0	31.0	0.0	22.5%	32.0	71.0	2.0	30.5%

Fundamentals of Rockwell Medical Inc

About Rockwell Medical Inc

https://www.rockwellmed.com
237
30142 South Wixom road, Wixom, MI, United States, 48393
Google Maps Bing Maps

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Fundamental data was last updated by Penke on 2024-04-12 16:50:06.

Financial Health

Profitability Details

	Compared to previous year	Compared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.

Operating Efficiency Details

	Compared to previous year	Compared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.

Liquidity Details

	Compared to previous year	Compared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.

Solvency Details

	Compared to previous year	Compared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details

	Compared to previous year	Compared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Rockwell Medical Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Measures how much net profit Rockwell Medical Inc earns for each $1 of revenue.

Above 10% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
A Net Profit Margin of -6.8% means that $-0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Rockwell Medical Inc:

The MRQ is -6.8%. The company is making a loss. -1
The TTM is -11.4%. The company is making a huge loss. -2

Trends

Current period		Compared to		+/-
MRQ	-6.8%	TTM	-11.4%	+4.5%
TTM	-11.4%	YOY	-31.7%	+20.3%
TTM	-11.4%	5Y	-40.3%	+28.9%
5Y	-40.3%	10Y	-40.2%	-0.1%

Measures how much net profit Rockwell Medical Inc earns for each $1 of revenue.

Revenue is the amount of profit Rockwell Medical Inc generates before taxes and all other costs. For example, when you buy a cup of coffee it will cost you $3. The company does not earn $3 in profit but also has to pay various costs and taxes to create that cup of coffee. Let's assume the cost of creating a cup of coffee is $1.5.

The $3 you pay for a cup of coffee is called revenue.
The $1.5 that’s left over when all costs to create that cup of coffee (including taxes) are deduced from the revenue is called net profit.

The net profit margin looks at how much net profit Rockwell Medical Inc earns for each $1 in revenue.

How to use net profit margin

Higher profit margin is better (more profit).
Above 10% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be used to compare companies within the Drug Manufacturers - Specialty & Generic industry.

You typically want a high profit margin. This means that for each $1 in sales, Rockwell Medical Inc makes more profit. This shows the investor how efficiently Rockwell Medical Inc is operating in general and compared to other companies in the same industry. Rockwell Medical Inc operates in the Drug Manufacturers - Specialty & Generic industry.

Why do investors use net profit margin in their analysis

It helps investors to determine the efficiency of Rockwell Medical Inc. If profit margins remain low (compared to the Drug Manufacturers - Specialty & Generic industry mean) and there are no improvements to make in production costs or other areas that might be a warning sign. If profit margins are high that means the company has low overhead costs and is efficiently using its resources to generate profit.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Net Profit Margin of Rockwell Medical Inc is -0.07. This means that Rockwell Medical Inc earned $-0.07 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Net Profit Margin of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare Rockwell Medical Inc with other companies in the same industry (Drug Manufacturers - Specialty & Generic).
Net profit margin should rise over the years.
Can be influenced when Rockwell Medical Inc sells assets (profit will increase while costs remain the same).
It won’t show what part of Rockwell Medical Inc is doing great or needs improvement (it only looks at total revenue and total net income).

How to calculate net profit margin

Net profit margin = net income / total revenue * 100%

Real example of Rockwell Medical Inc

You need the following data to determine net profit margin:

Income statement from the period you want to calculate (for example, MRQ or TTM).

Net income MRQ Rockwell Medical Inc = -1,512
Total revenue MRQ Rockwell Medical Inc = 22,093
$-1,512 / $22,093 = -0.07 or -6.8%

Higher is better

The higher the net profit margin, the more efficient the company is generating income. This helps investors to determine how the company is managing money. The net profit margin is an important indicator when diving into the financial health of a company. Overall, you want to see the net profit margin rising over the years. That means the company improved their production and made it more efficient (if possible).

You can use the net profit margin to compare companies within the same industry. If there are two companies where one is much bigger but the smaller one has a higher net profit margin, that means the smaller company is more efficiently using operational costs.

Important: Profit margins can be very different between industries. Companies with assembly lines or transports are much more prone to see shifting in prices for fuel, ingredients and maintenance compared to companies that only provide services. You should never compare net profit margin between different industries.

1.1.2. Return on Assets

Shows how efficient Rockwell Medical Inc is using its assets to generate profit.

Above 5% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
-2.9% Return on Assets means that Rockwell Medical Inc generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Rockwell Medical Inc:

The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
The TTM is -5.3%. Using its assets, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-2.9%	TTM	-5.3%	+2.4%
TTM	-5.3%	YOY	-10.5%	+5.2%
TTM	-5.3%	5Y	-11.6%	+6.3%
5Y	-11.6%	10Y	-11.2%	-0.4%

Shows how efficient Rockwell Medical Inc is using its assets to generate profit.

For a farm, a tractor is considered an asset. The tractor helps ploughing the land making it possible to plant and harvest crops. But the tractor might be old and needing maintenance all the time reducing its efficiency. Return on assets indicates how effectively the farm is using the tractor (and other assets that help the core business) to plough the land.

How to use return on assets

Higher is better.
Above 5% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on assets in their analysis

Shows the investor how effectively Rockwell Medical Inc is using its resources to generate profit. If the return on assets (-2.9%) from Rockwell Medical Inc are higher than the Drug Manufacturers - Specialty & Generic mean () that means Rockwell Medical Inc is using its resources better than their competitors. If not, that means their competitors are more efficient in using their resources to generate profit.

An investor should always look at:

What is the current return on assets?
The current most recent quarter (MRQ) Return on Assets of Rockwell Medical Inc is -2.9%. This means the company generated $-0.03 for each $1 in assets.
How does it compare to the industry?
The mean MRQ Return on Assets of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
If a company has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

How to calculate return on assets

Return on assets = net income / total assets * 100%

Real example Rockwell Medical Inc

You need the following data to determine return on assets (ROA):

Income statement
Balance sheet

Net income MRQ (income statement) from Rockwell Medical Inc = -1,512
Total assets MRQ (balance sheet) from Rockwell Medical Inc = 52,173
-1,512 / 52,173 = -0.03 or -2.9%

ROA is an important ratio as it will tell you how effectively Rockwell Medical Inc is using its resources to generate profits. Example:

Bob and Kristin both sell ice cream in the summer. They both have an ice cream truck. The truck Bob owes cost him $20.000 and the truck Kristin owes cost her $1500. Over the summer, Bob earned $2000 and Kristin earned $200. To calculate the return on assets:

Bob: $2000 / $20.000 * 100% = 10%
Kristin: $200 / $1500 * 100% = 13.3%

This tells you Bob’s company is more valuable but Kristin's company is more efficient. Be aware that total assets can change over time. A transportation business will buy and sell trucks or planes all the time. Before using return on assets as a guideline, you have to know what the exact assets are. For a company that has many assets changing over time, it’s better to calculate the average assets instead of the total assets.

1.1.3. Return on Equity

Shows how efficient Rockwell Medical Inc is using its investors money to generate profit.

Above 15%-20% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
-7.1% Return on Equity means Rockwell Medical Inc generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Rockwell Medical Inc:

The MRQ is -7.1%. Using its investors money, the company is very inefficient in making profit. -2
The TTM is -17.7%. Using its investors money, the company is very inefficient in making profit. -2

Trends

Current period		Compared to		+/-
MRQ	-7.1%	TTM	-17.7%	+10.6%
TTM	-17.7%	YOY	-107.1%	+89.4%
TTM	-17.7%	5Y	-63.2%	+45.6%
5Y	-63.2%	10Y	-39.2%	-24.1%

Shows how efficient Rockwell Medical Inc is using its investors money to generate profit.

A publicly traded company (any company that issues shares to the public) is owned by its shareholders. Return on equity calculates the amount of profit for every $1 the shareholders invested.

How to use return on equity

Higher is better.
Above 15%-20% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use return on equity in their analysis

To find out the owners/management's attitude toward their company. You typically want the owners/management to invest in the company and focus on generating profit. If not enough profit is generated (compared to the Drug Manufacturers - Specialty & Generic industry mean), the company might not be investing their money efficiently.

The three steps every investor should look at:

What is the current return on equity?
The current most recent quarter (MRQ) Return on Equity of Rockwell Medical Inc is -7.1%. This means Rockwell Medical Inc generated $-0.07 for each $1 the owners (shareholders) invested.
How does it compare to the industry?
The mean MRQ Return on Equity of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if Rockwell Medical Inc existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Does not include intangible assets (non physical assets like licences, computer software, etc.).
Stockholders equity and shareholders equity refer to the same thing.
Liabilities should not be more than three times return on equity.

How to calculate return on equity

Return on equity = net profit / shareholders equity * 100%

Real example of Rockwell Medical Inc

You need the following data to determine ROE:

Income statement
Balance sheet
Net profit MRQ (income statement) Rockwell Medical Inc = -1,512
Shareholders equity (balance sheet) MRQ Rockwell Medical Inc = 21,291
-1,512 / 21,291 = -0.07 or -7.1%

A negative shareholder equity is a warning sign. It means the company has more liabilities than assets. It might also mean that the owners did not invest enough money or they are taking money out of the business.

1.2. Operating Efficiency of Rockwell Medical Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Measures how efficient Rockwell Medical Inc is operating .

Measures how much profit Rockwell Medical Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
Above 15% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
An Operating Margin of -2.5% means the company generated $-0.02 for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Rockwell Medical Inc:

The MRQ is -2.5%. The company is operating very inefficient. -2
The TTM is -8.9%. The company is operating very inefficient. -2

Trends

Current period		Compared to		+/-
MRQ	-2.5%	TTM	-8.9%	+6.4%
TTM	-8.9%	YOY	-27.1%	+18.2%
TTM	-8.9%	5Y	-37.9%	+29.1%
5Y	-37.9%	10Y	-38.4%	+0.5%

Measures how efficient Rockwell Medical Inc is operating .

The more effecient a company creates products or provides services, the more profit it generates.

How to use operating margin

Higher is better
Above 15% is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries
Can be used to compare companies

Why do investors use operating margin in their analysis

To determine how much profit Rockwell Medical Inc is making from it’s core business.

The three steps every investor should look at:

What is the current net profit margin?
The current most recent quarter (MRQ) Operating Margin of Rockwell Medical Inc is -2.5%. This means that Rockwell Medical Inc earned $-0.02 for each $1 in revenue in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Margin of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Can be calculated in different ways

How to calculate operating margin

Operating margin = operating earnings / total revenue

Real example of Rockwell Medical Inc

You need the following data to determine operating margin:

Income statement
Operating earnings MRQ Rockwell Medical Inc = -547
Total revenue MRQ Rockwell Medical Inc = 22,093
$-547 / $22,093 = -0.02 or -2.5%

Operating margin is used to calculate how much profit a company makes after variable costs of production but before paying interest and taxes. Some variable costs examples are wages, raw materials, packaging, and transaction fees. The amount of variable costs is different for each company and industry. In general, a higher operating margin is better as this implicates that a company is running efficiently.

For investors, a higher operating margin is a good sign. Although you should always look at operating margin in the long term. If operating margin is fluctuating over the years this might be a sign that things are not running efficiently enough. It’s a way to check how much profit a company is making from its core business.

Operation earnings can be calculated in multiple ways:

Operation earnings = EBIT - non operating income + non operating expense
Operation earnings = Gross profit - operating expense - depreciation and amortisation
Operation earnings = Total revenue - COGS (costs of goods sold) - indirect costs

1.2.2. Operating Ratio

Measures how efficient Rockwell Medical Inc is keeping operating costs low.

Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
An Operation Ratio of 1.02 means that the operating costs are $1.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Rockwell Medical Inc:

The MRQ is 1.025. The company is inefficient in keeping operating costs low. -1
The TTM is 1.084. The company is inefficient in keeping operating costs low. -1

Trends

Current period		Compared to		+/-
MRQ	1.025	TTM	1.084	-0.059
TTM	1.084	YOY	1.271	-0.188
TTM	1.084	5Y	1.429	-0.346
5Y	1.429	10Y	1.409	+0.020

Measures how efficient Rockwell Medical Inc is keeping operating costs low.

If the operating ratio is below 1 that means the company is making money. The lower the operating ratio, the more efficient the company.

How to use operating ratio

Lower is better.
Below 1 is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use operating ratio in their analysis

Shows if costs of creating products and or services is increasing or decreasing. The lower the operating ratio, the more efficient the company is creating products and services.

The three steps every investor should look at:

What is the current Operatin ratio?
The current most recent quarter (MRQ) Operating Ratio of Rockwell Medical Inc is 102.5%. This means that Rockwell Medical Inc earned $1.02 for each $1 in net sales in the most recent quarter.
How does it compare to the industry?
The mean MRQ Operating Ratio of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
You need COGS to calculate operating ratio which is not always shown in the income statement.
Does not consider debt.

How to calculate operating ratio

Operating ratio = Operating expenses + COGS \ Net sales

Real life example Rockwell Medical Inc

You need the following data to determine operating ratio:

Income statement

COGS is not always specified on the income statement. If so you can use the following calculation:

(cost of revenue + total operating expenses) \ total revenue
(19,223 +3,417) \ 22,093 = 1.02

The operating ratio measures the efficiency of a company at keeping low costs while generating profits from sales. It compares the total operating expenses to the net amount of sales. The total operating expenses exists of:

COGS (materials, labour, rent of facility, repairs)
Operating expenses (legal fees, marketing, wages, rent, maintenance/repairs)

Operating expenses are all the costs the company makes that are not directly tied to the production of the service or product. Where COGS are costs that are directly tied to the production of a product or service.

Do note that COGS is not always available in the income statement. Some companies include COGS in the operating expenses while others list COGS separately. To make it even more confusing, COGS is also known as “costs of sales” and costs of sales is the same as costs of revenue.

The operating ratio tells you how efficient the company is creating its products or services while keeping prices low. In this case, a lower ratio is better. Higher or rising operating ratios might tell you that costs are rising while sales are not improving or staying the same.

1.3. Liquidity of Rockwell Medical Inc.

1.3. Liquidity

1.3.1. Current Ratio

Measures if Rockwell Medical Inc is able to pay off Short-term Debt.

Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
A Current Ratio of 1.73 means the company has $1.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Rockwell Medical Inc:

The MRQ is 1.729. The company is able to pay all its short-term debts. +1
The TTM is 1.649. The company is able to pay all its short-term debts. +1

Trends

Current period		Compared to		+/-
MRQ	1.729	TTM	1.649	+0.081
TTM	1.649	YOY	2.105	-0.456
TTM	1.649	5Y	2.910	-1.261
5Y	2.910	10Y	4.909	-2.000

Measures if Rockwell Medical Inc is able to pay off Short-term Debt.

How to use current ratio

Higher is better
Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
Can be very different between industries
Can be used to compare companies

Why do investors use current ratio in their analysis

Shows if the company can pay of short term debts if needed. A company that can't pay off it's short term debts might get in trouble if they have to pay off their short term debts for whatever reason. For example, markets can change due to global events like covid-19 or the war in Ukraine versus Russia. Because debts are always taken based on future income, it might become troublesome for Rockwell Medical Inc if something happens in the market that will cause sales to plummet.

The three steps every investor should look at:

What is the current current Ratio?
The current most recent quarter (MRQ) Current Ratio of Rockwell Medical Inc is 1.73. This means Rockwell Medical Inc has $1.73 in assets for each $1 in short-term debts.
How does it compare to the industry?
The mean MRQ Current Ratio of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Might be deluded.
Not all assets can always be quickly sold.
Can be manipulated by increasing or decreasing the assets and/or liabilities.

How to calculate current ratio

Current ratio = current assets \ current liabilities

Real life example Rockwell Medical Inc

You need the following data to determine operating ratio:

Balance sheet
Current ratio = current assets \ current liabilities
28,770 \ 16,637) = 1.73

The current ratio measures if Rockwell Medical Inc is able to pay short-term debts (obligations). Short term in this context means all debt obligations that are about to expire within one year. The current ratio incorporates current liabilities and current assets. Current assets are all the assets a company has that are expected to be consumed or sold within standard business operations. You can find the current assets in the balance sheet. They consist of:

Inventory
Accounts receivable
Marketable securities
Prepaid expenses
Cash
Cash equivalents
liquid assets

The current liabilities are short term obligations that are due within one year. These consist of:

Short term debts
Dividends
Income taxes
Short-term debts
Accounts payable
Interest payments

The result shows an investor if Rockwell Medical Inc is able to pay all its short-term debts if they were due all at once. When the result of the above formula is below 1, then Rockwell Medical Inc does not have enough capital after selling all its assets to pay all short-term debts. If the ratio drops far below 1 that might indicate Rockwell Medical Inc is or will be in financial trouble anytime soon.

Although this gives an investor some clues, the current ratio may also be deluded. Because owning assets does not mean the company can easily sell them. Also, Accounts receivable may be quite old (they will probably never pay) which deludes the current ratio. As with all ratios, you should only compare them between the same industries and companies.

1.3.2. Quick Ratio

Measures if Rockwell Medical Inc is able to pay off Short-term Debt but only using the most liquid assets.

Above 1 is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
A Quick Ratio of 1.43 means the company can pay off $1.43 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Rockwell Medical Inc:

The MRQ is 1.430. The company is able to pay all its short-term debts with the most liquid assets. +1
The TTM is 1.418. The company is able to pay all its short-term debts with the most liquid assets. +1

Trends

Current period		Compared to		+/-
MRQ	1.430	TTM	1.418	+0.012
TTM	1.418	YOY	2.165	-0.747
TTM	1.418	5Y	3.016	-1.598
5Y	3.016	10Y	6.017	-3.001

Measures if Rockwell Medical Inc is able to pay off Short-term Debt but only using the most liquid assets.

How to use quick ratio

Higher is better.
Above 1 is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use quick ratio in their analysis

Shows how fast Rockwell Medical Inc can pay off its short term debts. This shows if Rockwell Medical Inc can survive emergencies due to market changes or other reasons.

The three steps every investor should look at:

What is the current Quick Ratio?
The current most recent quarter (MRQ) quickRatio of Rockwell Medical Inc is 1.43. This means that Rockwell Medical Inc can pay off $1.43 for each $1 in debt (using most liquid assets).
How does it compare to the industry?
The mean MRQ Quick Ratio of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Incorporates only most liquid assets.

How to calculate quick ratio

Quick ratio = cash and equivalents + marketable securities + accounts receivable / current liabilities

Real life example Rockwell Medical Inc

You need the following data to determine operating ratio:

Balance sheet
Quick ratio = cash and short-term investments + short-term investments + netReceivables / total current liabilities
MRQ quick ratio Rockwell Medical Inc: (10,935 + 1,952 +10,901) / 16,637 = 1.43

The quick ratio measures the same thing as the current ratio, only it uses the most liquid assets a company has. Meaning, the assets that can be sold for cash the easiest and fastest.

As the quick ratio only incorporates the most liquid assets, you should also check the current ratio which also includes less liquid assets. But they may be harder to sell.

1.4. Solvency of Rockwell Medical Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Measures how much % of Rockwell Medical Inc assets are financed with debt.

Below 1 (100%) is considered healthy but always compare Rockwell Medical Inc to Drug Manufacturers - Specialty & Generic industry mean.
A Debt to Asset Ratio of 0.59 means that Rockwell Medical Inc assets are financed with 59.2% credit (debt) and the remaining percentage (100% - 59.2%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Rockwell Medical Inc:

The MRQ is 0.592. The company is able to pay all its debts by selling its assets. +1
The TTM is 0.656. The company is able to pay all its debts by selling its assets. +1

Trends

Current period		Compared to		+/-
MRQ	0.592	TTM	0.656	-0.064
TTM	0.656	YOY	0.752	-0.096
TTM	0.656	5Y	0.665	-0.010
5Y	0.665	10Y	0.585	+0.080

Measures how much % of Rockwell Medical Inc assets are financed with debt.

When there are more debts than assets, that means creditors have a larger stake Rockwell Medical Inc than its shareholders.

How to use debt to asset ratio

Lower is better.
below 1 (100%) is considered healthy but always compare Rockwell Medical Inc to Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to asset ratio in their analysis

It shows how much debt the company used to finance its assets. If a company is almost entirely financed with debt that means the company might get into serious trouble when emergencies arise like a raise in interest.

The three steps every investor should look at:

What is the current debt to asset ratio?
The current most recent quarter (MRQ) Debt to Asset Ratio of Rockwell Medical Inc is 0.59. This means means that Rockwell Medical Inc is financed with 59.2% credit and the remaining percentage is financed by it's owners (shareholders).
How does it compare to the industry?
The mean MRQ Current Ratio of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry
Some companies can have higher debt to assets ratio's (for example, banks).
Debt to asset ratio should improve over the years.
If the debt to asset ratio is above 1, look at the industry mean and find out why Rockwell Medical Inc has so much debt.

How to calculate debt to asset ratio

Debt to asset ratio = total debt \ total assets

Real life example Rockwell Medical Inc

You need the following data to determine debt to asset ratio:

Balance sheet
Debt to asset ratio = total debt \ total assets
30,882 \ 52,173 = 59.2% or 0.59.

The debt to total assets ratio shows if the company is owned by creditors or shareholders. Or in other words, the total debt in relation to the total amount of assets. It shows how much debt the company used to finance its assets.

1.4.2. Debt to Equity Ratio

Measures if Rockwell Medical Inc is able to pay off its debts by using shareholders equity.

Below 2 is considered healthy but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
A Debt to Equity ratio of 145.0% means that company has $1.45 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Rockwell Medical Inc:

The MRQ is 1.450. The company is able to pay all its debts with equity. +1
The TTM is 2.040. The company is just not able to pay all its debts with equity.

Trends

Current period		Compared to		+/-
MRQ	1.450	TTM	2.040	-0.589
TTM	2.040	YOY	6.190	-4.150
TTM	2.040	5Y	3.553	-1.513
5Y	3.553	10Y	2.076	+1.477

Measures if Rockwell Medical Inc is able to pay off its debts by using shareholders equity.

How to use debt to equity ratio

Lower is better.
Below 2 is considered healthy (always use industry average).
Can be very different between industries.
Can be used to compare companies.

Why do investors use the debt to shareholders equity ratio in their analysis

It shows how much debt the company uses to finance their operations. Shareholders equity is whats left over when you subtract total liabilities from total assets. It's another way to meassure how much of Rockwell Medical Inc is financed with debt or own resources.

The three steps every investor should look at:

What is the current debt to equity ratio?
The current most recent quarter (MRQ) quickRatio of Rockwell Medical Inc is 1.45. This means that Rockwell Medical Inc can pay off $1.45 for each $1 in debt.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Not all debt is equally risky (for example, short term risk is less risky).

How to calculate debt to equity ratio

Debt to equity ratio = total debt \ shareholders equity.

Real life example Rockwell Medical Inc

You need the following data to determine equity ratio:

Balance sheet
Debt to equity ratio = total debt \ shareholders equity
30,882 \ 21,291 = 1.45 or 145.0%

Debt to equity measures the total debt versus the total shareholders equity. While the total debts to total assets ratio uses total assets, the debt to equity ratio looks at the total equity of shareholders. Where equity of shareholders are:

Common shares.
Preferred shares.
Retained earnings.

You can find the shareholders' equity in the balance sheet. A ratio between 0,5 and 1,5 is preferred. If the ratio is above 1.5, that would indicate creditors have significantly more stake (debt) in the company than the shareholders. In other words, the company is using a lot of debt to finance their operations.

Not all debt is equally risky. Meaning you can adjust the ratio by including or excluding certain amounts of debt. Short term debts are less risky because they have to be paid back within one year anyway. It’s much easier to plan one year ahead versus five or ten years.

2. Market Valuation of Rockwell Medical Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Rockwell Medical Inc generates.

Above 15 is considered overpriced but always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
A PE ratio of -9.17 means the investor is paying $-9.17 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Rockwell Medical Inc:

The EOD is -7.057. Based on the earnings, the company is expensive. -2
The MRQ is -9.167. Based on the earnings, the company is expensive. -2
The TTM is -9.254. Based on the earnings, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	-7.057	MRQ	-9.167	+2.110
MRQ	-9.167	TTM	-9.254	+0.087
TTM	-9.254	YOY	-1.962	-7.292
TTM	-9.254	5Y	-3.314	-5.940
5Y	-3.314	10Y	-8.355	+5.042

Measures how much money you pay for each share for every $1 in earnings Rockwell Medical Inc generates.

Indicates if the company’s shares are under or overvalued.

How to use PE ratio

Above 15 is considered overpriced but is hard to determine. Always compare Rockwell Medical Inc to the Drug Manufacturers - Specialty & Generic industry mean.
Can be very different between industries.
Can be used to compare companies.

Why do investors use PE ratio in their analysis

The PE ratio tells investors the current sentiment in the market for that company. As with every stock, the stock price never shows the real valuation of a company but rather how the market thinks how much the stock is worth.

In other words, the current stock price also incorporates any future earnings or business opportunities in the future. The best example is the stock market crash in 2000. The PE ratio for any internet based company was going through the roof. Only based on the general assumption the internet and all associated businesses would thrive in the future. But this was based on nothing. A business still needs a good product or service to be able to survive. Instead, every investor bought any stock which did something related to the internet. Result: huge market crash.

Many investors were willing to pay premium prices and that was causing the PE ratio to rise. A high PE ratio is a warning sign that investors might be overvaluing a stock based on future earnings.

The three steps every investor should look at:

What is the current PE Ratio?
The current most recent quarter (MRQ) PE Ratio of Rockwell Medical Inc is -9.17. This means the investor is paying $-9.17 for every $1 in earnings.
How does it compare to the industry?
The mean MRQ Quick Ratio of the Drug Manufacturers - Specialty & Generic industry is .
What is the trend?
The trend is important because it shows you how Rockwell Medical Inc is performing over time. The most recent quarter might be important if Rockwell Medical Inc released a new product or service. And you can use MRQ to see if they performed better vs last year. You can find all the trends for Rockwell Medical Inc up to 10 years back (depending if the company existed 10 years ago) when you exit this learning section.

Things to be aware of

Only compare with other companies in the same industry.
Some industries might have very high or very low PE ratios in general.
PE ratios can be high for several years, it does not mean a sudden collapse is imminent.
Earnings growth is not included in the PE ratio.

How to calculate PE ratio

PE ratio = market value per share \ earnings per share

Real life example Rockwell Medical Inc

You need the following data to determine the PE ratio:

Balance sheet
Income statement

The PE ratio is a very commonly used ratio to determine the value of a company by comparing the current stock price relative to its earnings per share (EPS). Before we can calculate the PE ratio we need to know the EPS. EPS is calculated as follows:

EPS = (net profit - preferred dividends) \ end of period outstanding shares*
Net profit = revenue - expenses
0 \ 28,652 = EPS
PE ratio MRQ = -9.17

* The net profit minus preferred dividends can be found in the incomestatement as netIncomeApplicableToCommonShares.

The PE value helps investors to determine if the current stock price is under or overvalued. It also projects future growth.

In general, a higher PE ratio means that investors predict higher future growth. If the PE ratio is too high, then investors expect way too much future growth the company can never fulfil. This is most likely to happen in faster moving companies like tech companies or automobile companies like Tesla. These are hot and booming markets where investors expect much future growth driven by new technology (electric cars). When looking at the current MRQ (most recent quarter) PE ratio of Tesla ( jan. 2021) it's about 247 while the average in the industry is only 6. That might be a clue that Tesla is trading for way too high prices compared to their current assets and is more based on future growth.

2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Rockwell Medical Inc:

The EOD is -124.075. Based on how much money comes from the company's main activities, the company is expensive. -2
The MRQ is -161.170. Based on how much money comes from the company's main activities, the company is expensive. -2
The TTM is -47.630. Based on how much money comes from the company's main activities, the company is expensive. -2

Trends

Current period		Compared to		+/-
EOD	-124.075	MRQ	-161.170	+37.095
MRQ	-161.170	TTM	-47.630	-113.540
TTM	-47.630	YOY	-5.222	-42.408
TTM	-47.630	5Y	-11.831	-35.799
5Y	-11.831	10Y	3.543	-15.374

2. Book Value per Share

2.3. Price to Book Ratio

Measures if the stock price of Rockwell Medical Inc is to cheap or to expensive compared to its book value.

At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
A PB ratio of 2.60 means the investor is paying $2.60 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Rockwell Medical Inc:

The EOD is 2.005. Based on the equity, the company is underpriced. +1
The MRQ is 2.604. Based on the equity, the company is underpriced. +1
The TTM is 6.621. Based on the equity, the company is overpriced. -1

Trends

Current period		Compared to		+/-
EOD	2.005	MRQ	2.604	-0.599
MRQ	2.604	TTM	6.621	-4.017
TTM	6.621	YOY	2.961	+3.660
TTM	6.621	5Y	4.199	+2.422
5Y	4.199	10Y	-1.860	+6.058

2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Rockwell Medical Inc.

3.1. Institutions holding Rockwell Medical Inc

Institutions are holding 17.494% of the shares of Rockwell Medical Inc.

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2023-12-31	Armistice Capital, LLC	6.3576	0.0478	1852000	-965000	-34.2563
2023-12-31	Vanguard Group Inc	3.6902	0	1074975	698160	185.2792
2023-12-31	Richmond Brothers Inc	1.4158	1.3589	412433	2081	0.5071
2023-12-31	Perkins Capital Management Inc	1.2013	0.5646	349934	274891	366.3113
2023-12-31	Geode Capital Management, LLC	0.9747	0.0001	283923	40915	16.8369
2023-12-31	Raymond James & Associates	0.7586	0.0003	220979	30309	15.8961
2023-12-31	BlackRock Inc	0.6117	0	178201	-354	-0.1983
2023-12-31	Marshall Wace Asset Management Ltd	0.6011	0.0006	175096	-66805	-27.6167
2023-12-31	Renaissance Technologies Corp	0.3371	0.0003	98200	84157	599.2808
2023-12-31	State Street Corporation	0.2551	0	74304	40700	121.1165
2023-12-31	Northern Trust Corp	0.2191	0	63838	106	0.1663
2023-12-31	Susquehanna International Group, LLP	0.1704	0	49632	-100349	-66.9078
2023-12-31	Two Sigma Investments LLC	0.1639	0.0002	47733	47733	0
2023-12-31	HighTower Advisors, LLC	0.1122	0.0001	32698	-22	-0.0672
2023-12-31	JANE STREET GROUP, LLC	0.1108	0	32279	6156	23.5654
2023-12-31	WEALTHTRUST AXIOM LLC	0.1081	0.0199	31500	10400	49.2891
2023-12-31	Morgan Stanley - Brokerage Accounts	0.0908	0	26463	-7496	-22.0737
2023-12-31	Squarepoint Ops LLC	0.0842	0.0001	24522	24522	0
2023-12-31	GREAT VALLEY ADVISOR GROUP, INC.	0.0617	0.0012	17961	0	0
2023-12-31	SkyOak Wealt, LLC	0.0585	0.0084	17045	-2500	-12.791
Total		17.3829	2.0025	5063716	+117604	+2.3%

3.2. Funds holding Rockwell Medical Inc

Date	Name	Total Shares	Total Assets	Current Shares	Change	%
2024-02-29	Vanguard Total Stock Mkt Idx Inv	2.5895	0.0001	759624	0	0
2024-02-29	Vanguard Institutional Extnd Mkt Idx Tr	1.0661	0.0004	312724	388	0.1242
2024-02-29	Fidelity Extended Market Index	0.5463	0.0006	160265	-777	-0.4825
2023-09-30	BlackRock Extended Mkt Composite	0.2891	0.0013	84818	64838	324.5145
2024-03-31	BlackRock Extended Equity Market K	0.2523	0.0008	74023	27	0.0365
2024-02-29	Fidelity Total Market Index	0.1372	0.0001	40248	0	0
2024-02-29	Fidelity Series Total Market Index	0.129	0.0001	37836	0	0
2023-12-31	NT Ext Equity Mkt Idx Fd - NL	0.1197	0.0011	35116	0	0
2023-12-31	NT Ext Equity Mkt Idx Fd - DC - NL - T2	0.0961	0.0011	28203	53	0.1883
2024-03-28	iShares Micro-Cap ETF	0.0918	0.0049	26926	0	0
2023-12-31	Northern Trust Extended Eq Market Idx	0.0881	0.0008	25830	0	0
2023-12-31	NT Ext Equity Mkt Idx Fd - L	0.0881	0.0008	25830	0	0
2024-02-29	Fidelity Nasdaq Composite Index	0.0701	0.0002	20574	0	0
2024-02-29	Spartan Total Market Index Pool E	0.063	0.0001	18469	0	0
2023-12-31	Perkins Discovery	0.062	0.4506	18181	0	0
2024-02-29	Spartan Extended Market Index Pool E	0.038	0.0006	11160	777	7.4834
2024-03-31	Extended Equity Market Fund M	0.0311	0.0008	9131	-18	-0.1967
2024-02-29	Schwab Total Stock Market Index	0.0267	0.0001	7846	0	0
2024-02-29	Vanguard U.S. Eq Idx £ Acc	0.0103	0	3015	0	0
2024-03-31	State St US Extended Mkt Indx NL Cl C	0.0088	0.0002	2595	0	0
Total		5.8033	0.4647	1702414	+65288	+3.8%

3.3. Insider Transactions

Insiders are holding 3.005% of the shares of Rockwell Medical Inc.

Date	Owner	Type	Amount	Price	Post Transaction Amount	Link
2020-12-21	David S Richmond	SELL	42450	1.03

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Rockwell Medical Inc compared to the Most Recent Quarter (MRQ).

	End of day	+/-	Most Recent Quarter	Trailing 12 Months	+/-	Year-Over-Year	+/-	5 Year	+/-	10 Year	+/-
Book Value Change Per Share	-	-	-0.008	0.061	-113%	0.113	-107%	-0.010	+32%	0.018	-144%
Book Value Per Share	-	-	0.726	0.553	+31%	0.451	+61%	0.651	+11%	1.003	-28%
Current Ratio	-	-	1.729	1.649	+5%	2.105	-18%	2.910	-41%	4.909	-65%
Debt To Asset Ratio	-	-	0.592	0.656	-10%	0.752	-21%	0.665	-11%	0.585	+1%
Debt To Equity Ratio	-	-	1.450	2.040	-29%	6.190	-77%	3.553	-59%	2.076	-30%
Dividend Per Share	-	-	-	-	0%	0.008	-100%	0.111	-100%	0.055	-100%
Eps	-	-	-0.052	-0.072	+40%	-0.159	+209%	-0.202	+292%	-0.198	+284%
Free Cash Flow Per Share	-	-	-0.003	-0.083	+2719%	-0.145	+4840%	-0.194	+6513%	-0.157	+5256%
Free Cash Flow To Equity Per Share	-	-	-0.028	0.014	-301%	0.006	-572%	-0.002	-92%	0.008	-456%
Gross Profit Margin	-	-	1.358	1.254	+8%	1.121	+21%	1.210	+12%	1.105	+23%
Intrinsic Value_10Y_max	-	-	11.035	-	-	-	-	-	-	-	-
Intrinsic Value_10Y_min	-	-	-0.813	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_max	-	-	-0.370	-	-	-	-	-	-	-	-
Intrinsic Value_1Y_min	-	-	-0.539	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_max	-	-	0.014	-	-	-	-	-	-	-	-
Intrinsic Value_3Y_min	-	-	-1.232	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_max	-	-	1.753	-	-	-	-	-	-	-	-
Intrinsic Value_5Y_min	-	-	-1.497	-	-	-	-	-	-	-	-
Market Cap	42681843.000	-30%	55442394.000	82430226.000	-33%	30040830.495	+85%	57636648.187	-4%	148056139.444	-63%
Net Profit Margin	-	-	-0.068	-0.114	+66%	-0.317	+363%	-0.403	+489%	-0.402	+488%
Operating Margin	-	-	-0.025	-0.089	+259%	-0.271	+995%	-0.379	+1432%	-0.384	+1451%
Operating Ratio	-	-	1.025	1.084	-5%	1.271	-19%	1.429	-28%	1.409	-27%
Pb Ratio	2.005	-30%	2.604	6.621	-61%	2.961	-12%	4.199	-38%	-1.860	+171%
Pe Ratio	-7.057	+23%	-9.167	-9.254	+1%	-1.962	-79%	-3.314	-64%	-8.355	-9%
Price Per Share	1.455	-30%	1.890	2.810	-33%	1.024	+85%	1.920	-2%	5.025	-62%
Price To Free Cash Flow Ratio	-124.075	+23%	-161.170	-47.630	-70%	-5.222	-97%	-11.831	-93%	3.543	-4649%
Price To Total Gains Ratio	-188.026	+23%	-244.240	-81.560	-67%	-4.270	-98%	-18.550	-92%	-77.405	-68%
Quick Ratio	-	-	1.430	1.418	+1%	2.165	-34%	3.016	-53%	6.017	-76%
Return On Assets	-	-	-0.029	-0.053	+83%	-0.105	+264%	-0.116	+299%	-0.112	+285%
Return On Equity	-	-	-0.071	-0.177	+149%	-1.071	+1408%	-0.632	+790%	-0.392	+451%
Total Gains Per Share	-	-	-0.008	0.061	-113%	0.122	-106%	0.100	-108%	0.073	-111%
Usd Book Value	-	-	21291000.000	16219750.000	+31%	13230500.000	+61%	19190833.850	+11%	29477102.150	-28%
Usd Book Value Change Per Share	-	-	-0.008	0.061	-113%	0.113	-107%	-0.010	+32%	0.018	-144%
Usd Book Value Per Share	-	-	0.726	0.553	+31%	0.451	+61%	0.651	+11%	1.003	-28%
Usd Dividend Per Share	-	-	-	-	0%	0.008	-100%	0.111	-100%	0.055	-100%
Usd Eps	-	-	-0.052	-0.072	+40%	-0.159	+209%	-0.202	+292%	-0.198	+284%
Usd Free Cash Flow	-	-	-86000.000	-2424000.000	+2719%	-4248500.000	+4840%	-6001250.000	+6878%	-4763174.175	+5439%
Usd Free Cash Flow Per Share	-	-	-0.003	-0.083	+2719%	-0.145	+4840%	-0.194	+6513%	-0.157	+5256%
Usd Free Cash Flow To Equity Per Share	-	-	-0.028	0.014	-301%	0.006	-572%	-0.002	-92%	0.008	-456%
Usd Market Cap	42681843.000	-30%	55442394.000	82430226.000	-33%	30040830.495	+85%	57636648.187	-4%	148056139.444	-63%
Usd Price Per Share	1.455	-30%	1.890	2.810	-33%	1.024	+85%	1.920	-2%	5.025	-62%
Usd Profit	-	-	-1512000.000	-2287250.000	+51%	-5454750.000	+261%	-6432965.750	+325%	-6080924.475	+302%
Usd Revenue	-	-	22093000.000	20903000.000	+6%	18004500.000	+23%	17052965.500	+30%	15614288.000	+41%
Usd Total Gains Per Share	-	-	-0.008	0.061	-113%	0.122	-106%	0.100	-108%	0.073	-111%
	EOD	+3 -5	MRQ	TTM	+23 -11	YOY	+24 -12	5Y	+24 -12	10Y	+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Rockwell Medical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

Indicator	Condition		Value
Price to Earnings Ratio (EOD)	Between	0-15	-7.057
Price to Book Ratio (EOD)	Between	0-1	2.005
Net Profit Margin (MRQ)	Greater than	0	-0.068
Operating Margin (MRQ)	Greater than	0	-0.025
Quick Ratio (MRQ)	Greater than	1	1.430
Current Ratio (MRQ)	Greater than	1	1.729
Debt to Asset Ratio (MRQ)	Less than	1	0.592
Debt to Equity Ratio (MRQ)	Less than	1	1.450
Return on Equity (MRQ)	Greater than	0.15	-0.071
Return on Assets (MRQ)	Greater than	0.05	-0.029
Total			3/10 (30.0%)

Create your own Stock Scanner

Investing is personal. The best investors buy stocks based on their own analysis. Create your personal Stock Scanner with the key performance indicators that are important to you.
Create your own Stock Scanner

4.3. Technical Score

Let's check the technical score of Rockwell Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Open	Greater than	Close	1.480
Total			1/1 (100.0%)

Create your own Symbol Scanner

Trading is personal. The best traders buy and sell based on their own technical analysis. Create your personal Symbol Scanner with the technical indicators that are important to you.
Create your own Symbol Scanner

Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

		2022-12-31		2023-03-31		2023-06-30		2023-09-30		2023-12-31
Accumulated Other Comprehensive Income		163	-7	156	-19	137	-69	68	-69	-1
EBITDA		-1,921	718	-1,203	-1,537	-2,740	1,003	-1,737	1,740	3

Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary

Total Assets	52,173
Total Liabilities	30,882
Total Stockholder Equity	21,291

	As reported
Total Liabilities	30,882
Total Stockholder Equity	+ 21,291
Total Assets	= 52,173

Assets

Total Assets	52,173
Total Current Assets	28,770
Long-term Assets	23,403

Total Current Assets

Total Current Assets (as reported)	28,770
Cash And Cash Equivalents	8,983
Short-term Investments	1,952
Net Receivables	10,901
Inventory	5,871
Other Current Assets	1,063
Total Current Assets (calculated)	28,770
+/-	0

Long-term Assets

Long-term Assets (as reported)	23,403
Property Plant Equipment	11,018
Goodwill	921
Intangible Assets	10,759
Long-term Assets Other	705
Long-term Assets (calculated)	23,403
+/-	0

Liabilities & Shareholders' Equity

Total Current Liabilities	16,637
Long-term Liabilities	14,245
Total Stockholder Equity	21,291

Total Current Liabilities

Total Current Liabilities (as reported)	16,637
Short-term Debt	2,183
Short Long Term Debt	244
Accounts payable	4,516
Other Current Liabilities	9,892
Total Current Liabilities (calculated)	16,835
+/-	198

Long-term Liabilities

Long-term Liabilities (as reported)	14,245
Long term Debt	8,293
Capital Lease Obligations	4,902
Long-term Liabilities Other	14
Long-term Liabilities (calculated)	13,209
+/-	1,036

Total Stockholder Equity

Total Stockholder Equity (as reported)	21,291
Common Stock	3
Retained Earnings	-397,198
Accumulated Other Comprehensive Income	-1
Other Stockholders Equity	418,487
Total Stockholder Equity (calculated)	21,291
+/-	0

Other

Capital Stock	3
Cash and Short Term Investments	10,935
Common Stock Shares Outstanding	28,652
Current Deferred Revenue	46
Liabilities and Stockholders Equity	52,173
Net Debt	4,456
Net Invested Capital	29,828
Net Working Capital	12,133
Property Plant and Equipment Gross	19,822
Short Long Term Debt Total	13,439

Balance Sheet

Currency in USD. All numbers in thousands.

Trend

2023-12-31

2023-09-30

2023-06-30

2023-03-31

2022-12-31

2022-09-30

2022-06-30

2022-03-31

2021-12-31

2021-09-30

2021-06-30

2021-03-31

2020-12-31

2020-09-30

2020-06-30

2020-03-31

2019-12-31

2019-09-30

2019-06-30

2019-03-31

2018-12-31

2018-09-30

2018-06-30

2018-03-31

2017-12-31

2017-09-30

2017-06-30

2017-03-31

2016-12-31

2016-09-30

2016-06-30

2016-03-31

2015-12-31

2015-09-30

2015-06-30

2015-03-31

2014-12-31

2014-09-30

2014-06-30

2014-03-31

2013-12-31

2013-09-30

2013-06-30

2013-03-31

2012-12-31

2012-09-30

2012-06-30

2012-03-31

2011-12-31

2011-09-30

2011-06-30

2011-03-31

2010-12-31

2010-09-30

2010-06-30

2010-03-31

2009-12-31

2009-09-30

2009-06-30

2009-03-31

2008-12-31

2008-09-30

2008-06-30

2008-03-31

2007-12-31

2007-09-30

2007-06-30

2007-03-31

2006-12-31

2006-09-30

2006-06-30

2006-03-31

2005-12-31

2005-09-30

2005-06-30

2005-03-31

2004-12-31

2004-09-30

2004-06-30

2004-03-31

2003-12-31

2003-09-30

2003-06-30

2003-03-31

2002-12-31

2002-09-30

2002-06-30

2002-03-31

2001-12-31

2001-09-30

2001-06-30

2001-03-31

2000-12-31

2000-09-30

2000-06-30

2000-03-31

1999-12-31

1999-09-30

1999-06-30

1999-03-31

1998-12-31

1998-09-30

1998-06-30

1998-03-31

1997-12-31

1997-09-30

> Total Assets

3,600
3,400
6,500
5,900
5,400
5,300
4,900
4,500
4,300
4,500
4,107
3,833
3,845
4,052
4,052
4,330
4,788
6,058
6,058
6,804
6,727
6,454
6,573
6,345
6,660
7,045
7,776
7,484
7,358
7,701
9,585
9,756
9,412
9,261
15,190
14,121
13,593
13,153
11,911
12,204
12,347
22,803
22,100
21,764
21,159
18,960
16,067
15,933
15,839
34,879
35,480
36,827
36,220
36,967
34,890
34,102
34,590
31,940
39,423
34,091
24,221
17,025
17,968
54,028
43,601
36,362
26,794
25,882
23,872
98,000
97,161
91,526
90,916
87,822
89,098
87,143
82,854
83,154
80,457
69,476
65,806
58,780
51,957
41,418
38,084
52,558
48,745
57,076
48,087
44,316
66,826
58,585
85,236
77,748
69,449
63,684
58,699
48,574
48,574
59,116
54,186
46,635
40,472
38,037
52,606
52,173

52,173

52,606

38,037

40,472

46,635

54,186

59,116

48,574

58,699

63,684

69,449

77,748

85,236

58,585

66,826

44,316

48,087

57,076

48,745

52,558

38,084

41,418

51,957

58,780

65,806

69,476

80,457

83,154

82,854

87,143

89,098

87,822

90,916

91,526

97,161

98,000

23,872

25,882

26,794

36,362

43,601

54,028

17,968

17,025

24,221

34,091

39,423

31,940

34,590

34,102

34,890

36,967

36,220

36,827

35,480

34,879

15,839

15,933

16,067

18,960

21,159

21,764

22,100

22,803

12,347

12,204

11,911

13,153

13,593

14,121

15,190

9,261

9,412

9,756

9,585

7,701

7,358

7,484

7,776

7,045

6,660

6,345

6,573

6,454

6,727

6,804

6,058

4,788

4,330

4,052

3,845

3,833

4,107

4,500

4,300

4,500

4,900

5,300

5,400

5,900

6,500

3,400

3,600

> Total Current Assets

1,000
900
4,300
3,500
3,000
2,900
2,600
2,400
2,300
2,500
2,237
2,053
2,081
1,971
1,971
1,914
2,190
2,666
2,666
3,537
3,501
3,331
3,525
3,348
3,730
3,739
4,270
4,106
3,957
4,241
6,217
6,286
5,894
5,380
11,281
10,243
9,588
9,059
7,530
7,799
8,030
18,646
17,815
17,259
16,540
14,429
11,523
11,303
11,049
29,949
30,599
32,112
31,672
32,666
28,136
30,266
28,102
25,897
33,841
29,397
20,004
13,149
14,188
49,260
38,942
31,918
22,342
21,697
19,894
94,707
94,005
88,441
87,904
84,626
85,762
83,977
79,784
78,509
74,750
63,804
61,188
48,828
44,246
35,531
32,093
46,825
40,190
48,262
40,565
36,874
59,494
51,536
77,943
69,469
59,242
52,399
46,082
35,288
35,288
47,245
42,358
35,310
29,690
27,565
28,173
28,770

28,770

28,173

27,565

29,690

35,310

42,358

47,245

35,288

46,082

52,399

59,242

69,469

77,943

51,536

59,494

36,874

40,565

48,262

40,190

46,825

32,093

35,531

44,246

48,828

61,188

63,804

74,750

78,509

79,784

83,977

85,762

84,626

87,904

88,441

94,005

94,707

19,894

21,697

22,342

31,918

38,942

49,260

14,188

13,149

20,004

29,397

33,841

25,897

28,102

30,266

28,136

32,666

31,672

32,112

30,599

29,949

11,049

11,303

11,523

14,429

16,540

17,259

17,815

18,646

8,030

7,799

7,530

9,059

9,588

10,243

11,281

5,380

5,894

6,286

6,217

4,241

3,957

4,106

4,270

3,739

3,730

3,348

3,525

3,331

3,501

3,537

2,666

2,190

1,914

1,971

2,081

2,053

2,237

2,500

2,300

2,400

2,600

2,900

3,000

3,500

4,300

900

1,000

Cash And Cash Equivalents

100
100
3,500
2,500
2,100
1,900
1,300
1,100
1,000
1,100
836
480
446
211
211
28
0
83
83
12
59
0
50
28
213
107
369
306
62
166
866
1,276
451
299
5,695
4,748
4,035
2,663
2,663
0
0
11,097
10,641
9,736
7,482
5,597
3,353
3,335
2,768
23,038
24,634
24,200
23,657
12,263
7,952
9,318
8,422
5,715
13,639
6,470
1,174
4,712
5,774
40,952
21,213
11,881
661
2,859
3,017
65,800
63,333
37,146
33,173
31,198
30,008
23,822
19,293
17,181
11,900
8,328
3,888
8,407
3,278
1,748
4,292
22,714
20,920
21,417
14,421
11,795
37,400
26,697
56,614
48,682
35,675
32,378
23,390
13,280
13,280
30,780
12,980
21,492
10,894
8,959
7,759
8,983

8,983

7,759

8,959

10,894

21,492

12,980

30,780

13,280

23,390

32,378

35,675

48,682

56,614

26,697

37,400

11,795

14,421

21,417

20,920

22,714

4,292

1,748

3,278

8,407

3,888

8,328

11,900

17,181

19,293

23,822

30,008

31,198

33,173

37,146

63,333

65,800

3,017

2,859

661

11,881

21,213

40,952

5,774

4,712

1,174

6,470

13,639

5,715

8,422

9,318

7,952

12,263

23,657

24,200

24,634

23,038

2,768

3,335

3,353

5,597

7,482

9,736

10,641

11,097

2,663

4,035

4,748

5,695

299

451

1,276

866

166

306

369

107

213

211

446

480

836

1,100

1,000

1,100

1,300

1,900

2,100

2,500

3,500

100

Short-term Investments

0
0
0
0
0
0
0
0
0
0
0
0
0
150
0
0
0
293
0
0
0
14
0
0
0
9
0
0
0
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,938
12,035
12,139
11,814
11,811
11,911
13,916
10,078
0
0
0
10,005
12,035
14,068
9,076
9,017
19,927
19,998
40,115
39,818
39,483
39,436
40,612
38,434
40,760
40,841
34,914
35,029
24,648
24,822
20,937
13,410
10,818
6,876
13,816
14,576
14,250
11,456
13,258
10,702
9,997
10,464
8,574
9,813
9,158
9,158
0
14,584
11,390
5,940
5,906
3,971
1,952

1,952

3,971

5,906

5,940

11,390

14,584

9,158

9,813

8,574

10,464

9,997

10,702

13,258

11,456

14,250

14,576

13,816

6,876

10,818

13,410

20,937

24,822

24,648

35,029

34,914

40,841

40,760

38,434

40,612

39,436

39,483

39,818

40,115

19,998

19,927

9,017

9,076

14,068

12,035

10,005

10,078

13,916

11,911

11,811

11,814

12,139

12,035

11,938

293

150

Net Receivables

500
400
400
600
700
700
1,000
800
800
1,000
743
874
995
927
927
978
1,121
1,115
1,115
1,213
1,217
1,722
1,823
1,606
2,037
2,170
2,134
2,226
2,303
2,302
2,497
2,383
2,702
2,836
3,064
2,477
2,749
3,474
4,545
4,684
4,918
4,687
4,145
4,352
5,357
5,230
4,869
4,745
5,086
3,493
2,971
4,598
4,637
4,507
4,688
4,497
4,258
4,223
4,215
4,356
4,319
4,432
4,462
4,576
4,222
4,578
4,100
6,389
4,190
4,472
4,666
3,939
5,896
5,047
6,224
7,590
8,031
6,393
7,250
4,881
5,374
6,356
5,994
5,854
8,082
7,351
6,711
5,389
5,122
4,203
4,587
3,565
4,129
4,171
6,597
5,357
6,036
5,913
5,913
8,090
7,367
6,259
6,021
5,411
9,361
10,901

10,901

9,361

5,411

6,021

6,259

7,367

8,090

5,913

6,036

5,357

6,597

4,171

4,129

3,565

4,587

4,203

5,122

5,389

6,711

7,351

8,082

5,854

5,994

6,356

5,374

4,881

7,250

6,393

8,031

7,590

6,224

5,047

5,896

3,939

4,666

4,472

4,190

6,389

4,100

4,578

4,222

4,576

4,462

4,432

4,319

4,356

4,215

4,223

4,258

4,497

4,688

4,507

4,637

4,598

2,971

3,493

5,086

4,745

4,869

5,230

5,357

4,352

4,145

4,687

4,918

4,684

4,545

3,474

2,749

2,477

3,064

2,836

2,702

2,383

2,497

2,302

2,303

2,226

2,134

2,170

2,037

1,606

1,823

1,722

1,217

1,213

1,115

1,121

978

927

995

874

743

1,000

800

1,000

700

600

400

500

Inventory

400
300
300
300
200
0
300
300
400
400
579
603
526
585
585
656
808
1,067
1,067
2,160
2,069
1,477
1,531
1,570
1,355
1,350
1,611
1,433
1,438
1,652
2,650
2,380
2,063
2,052
2,212
2,545
2,547
2,660
2,657
2,821
2,794
2,559
2,672
2,712
3,167
3,162
2,816
2,813
2,675
3,088
2,546
2,863
2,535
2,937
2,782
2,358
2,235
2,504
2,410
2,762
2,672
2,650
2,866
2,917
2,814
2,800
2,910
2,784
2,982
3,920
5,196
6,315
7,415
7,872
9,164
11,010
11,760
12,141
13,421
13,774
14,865
7,637
8,545
4,520
4,647
4,039
4,002
3,973
3,583
3,647
4,293
4,557
3,877
3,913
4,117
4,677
4,028
4,076
4,076
5,171
5,020
5,814
5,595
5,814
5,486
5,871

5,871

5,486

5,814

5,595

5,814

5,020

5,171

4,076

4,028

4,677

4,117

3,913

3,877

4,557

4,293

3,647

3,583

3,973

4,002

4,039

4,647

4,520

8,545

7,637

14,865

13,774

13,421

12,141

11,760

11,010

9,164

7,872

7,415

6,315

5,196

3,920

2,982

2,784

2,910

2,800

2,814

2,917

2,866

2,650

2,672

2,762

2,410

2,504

2,235

2,358

2,782

2,937

2,535

2,863

2,546

3,088

2,675

2,813

2,816

3,162

3,167

2,712

2,672

2,559

2,794

2,821

2,657

2,660

2,547

2,545

2,212

2,052

2,063

2,380

2,650

1,652

1,438

1,433

1,611

1,350

1,355

1,570

1,531

1,477

2,069

2,160

1,067

808

656

585

526

603

579

400

300

200

300

400

> Long-term Assets

2,600
2,500
2,200
2,400
2,400
2,400
2,300
2,100
2,000
2,000
1,871
1,780
1,763
2,081
2,081
2,416
2,598
0
3,392
3,268
3,227
3,122
3,047
2,997
2,930
3,306
3,507
3,379
3,401
3,460
3,368
3,470
3,518
3,881
3,909
3,878
4,005
4,094
4,382
4,404
4,317
4,157
4,284
4,505
4,619
4,531
4,543
4,630
4,790
4,930
4,881
4,714
4,548
4,301
6,754
3,836
6,489
6,043
5,582
4,694
4,217
3,876
3,780
4,768
4,660
4,444
4,451
4,185
3,978
3,293
3,155
3,086
3,012
3,196
3,335
3,166
3,071
4,644
5,707
5,671
4,619
9,951
7,711
5,887
5,991
5,733
8,556
8,814
7,523
7,443
7,332
7,049
7,293
8,279
10,207
11,285
12,617
13,286
13,286
11,871
11,828
11,325
10,782
10,472
24,433
23,403

23,403

24,433

10,472

10,782

11,325

11,828

11,871

13,286

12,617

11,285

10,207

8,279

7,293

7,049

7,332

7,443

7,523

8,814

8,556

5,733

5,991

5,887

7,711

9,951

4,619

5,671

5,707

4,644

3,071

3,166

3,335

3,196

3,012

3,086

3,155

3,293

3,978

4,185

4,451

4,444

4,660

4,768

3,780

3,876

4,217

4,694

5,582

6,043

6,489

3,836

6,754

4,301

4,548

4,714

4,881

4,930

4,790

4,630

4,543

4,531

4,619

4,505

4,284

4,157

4,317

4,404

4,382

4,094

4,005

3,878

3,909

3,881

3,518

3,470

3,368

3,460

3,401

3,379

3,507

3,306

2,930

2,997

3,047

3,122

3,227

3,268

3,392

2,598

2,416

2,081

1,763

1,780

1,871

2,000

2,100

2,300

2,400

2,200

2,500

2,600

Property Plant Equipment

700
700
700
900
900
900
900
800
800
700
671
645
644
824
824
1,130
1,325
1,716
1,716
1,832
1,798
1,731
1,663
1,621
1,560
1,943
2,152
2,031
1,988
2,049
1,967
2,028
2,068
2,430
2,448
2,375
2,487
2,588
2,889
2,924
2,842
2,840
2,952
3,180
3,333
3,249
3,264
3,326
3,491
3,632
3,589
3,431
3,273
3,050
2,842
2,598
2,459
2,290
2,133
2,034
1,941
1,858
1,792
1,740
1,705
1,649
1,761
1,650
1,615
1,497
1,401
1,373
1,342
1,647
1,690
1,562
1,506
1,392
1,420
1,530
1,709
2,549
2,573
2,606
2,668
2,638
5,578
5,893
5,518
5,646
5,228
4,747
4,884
5,553
7,332
8,614
9,441
10,223
10,223
8,960
9,192
8,605
5,737
9,308
11,910
11,018

11,018

11,910

9,308

5,737

8,605

9,192

8,960

10,223

9,441

8,614

7,332

5,553

4,884

4,747

5,228

5,646

5,518

5,893

5,578

2,638

2,668

2,606

2,573

2,549

1,709

1,530

1,420

1,392

1,506

1,562

1,690

1,647

1,342

1,373

1,401

1,497

1,615

1,650

1,761

1,649

1,705

1,740

1,792

1,858

1,941

2,034

2,133

2,290

2,459

2,598

2,842

3,050

3,273

3,431

3,589

3,632

3,491

3,326

3,264

3,249

3,333

3,180

2,952

2,840

2,842

2,924

2,889

2,588

2,487

2,375

2,448

2,430

2,068

2,028

1,967

2,049

1,988

2,031

2,152

1,943

1,560

1,621

1,663

1,731

1,798

1,832

1,716

1,325

1,130

824

644

645

671

700

800

900

700

Goodwill

0
0
0
0
0
0
0
0
0
0
0
0
0
1,086
0
1,003
962
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921
921

921

962

1,003

1,086

Intangible Assets

1,500
0
1,400
1,400
1,300
1,300
1,200
1,200
0
1,100
1,079
1,040
1,001
1,086
1,086
0
0
921
921
347
1,263
1,257
1,251
1,245
1,241
1,235
1,229
1,223
1,290
1,290
1,282
1,325
1,321
1,316
407
450
468
458
446
434
429
270
263
256
248
241
235
235
230
214
206
199
191
167
160
153
840
834
792
750
709
667
625
583
541
500
458
416
374
333
291
249
207
166
124
82
43
4
4
4
4
4
4
921
921
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,326
0
10,897
10,759

10,759

10,897

2,326

921

124

166

207

249

291

333

374

416

458

500

541

583

625

667

709

750

792

834

840

153

160

167

191

199

206

214

230

235

241

248

256

263

270

429

434

446

458

468

450

407

1,316

1,321

1,325

1,282

1,290

1,223

1,229

1,235

1,241

1,245

1,251

1,257

1,263

347

921

1,086

1,001

1,040

1,079

1,100

1,200

1,300

1,400

1,500

Long-term Assets Other

400
1,800
100
100
200
200
200
100
1,200
200
120
95
119
171
171
283
311
755
755
168
166
135
133
131
129
127
126
125
123
121
119
117
129
135
134
132
130
128
126
126
126
126
149
149
117
121
123
148
148
164
165
164
164
164
2,832
164
2,269
1,998
1,736
988
647
430
442
1,524
1,492
1,375
1,311
1,198
1,068
542
542
542
542
463
601
601
601
2,328
3,362
3,217
1,985
6,478
4,214
2,360
2,402
2,174
2,056
2,000
1,084
876
1,184
1,382
1,488
1,805
1,954
1,750
2,255
2,142
2,142
1,990
1,715
1,799
1,798
243
705
705

705

243

1,798

1,799

1,715

1,990

2,142

2,255

1,750

1,954

1,805

1,488

1,382

1,184

876

1,084

2,000

2,056

2,174

2,402

2,360

4,214

6,478

1,985

3,217

3,362

2,328

601

463

542

1,068

1,198

1,311

1,375

1,492

1,524

442

430

647

988

1,736

1,998

2,269

164

2,832

164

165

164

148

123

121

117

149

126

128

130

132

134

135

129

117

119

121

123

125

126

127

129

131

133

135

166

168

755

311

283

171

119

120

200

1,200

100

200

100

1,800

400

> Total Liabilities

1,500
1,700
500
600
500
700
700
600
600
900
727
792
1,099
1,191
1,191
1,469
2,222
3,462
3,462
3,744
3,791
3,408
3,588
3,427
3,626
3,873
4,502
4,145
3,953
4,278
5,950
5,914
5,398
5,416
3,271
3,150
4,160
4,779
5,206
5,893
6,143
4,842
4,987
5,210
6,806
7,139
5,452
6,371
7,042
5,556
5,643
5,940
4,881
6,429
5,732
6,377
9,628
13,695
13,837
17,419
23,049
26,987
28,474
36,789
37,500
35,767
30,321
29,795
29,332
29,297
29,339
25,538
26,487
25,502
28,893
29,513
27,097
30,197
29,852
25,630
25,016
25,866
24,590
24,529
25,414
25,281
28,584
27,484
24,385
23,997
45,052
42,373
43,161
43,578
43,271
45,481
47,605
46,039
46,039
38,971
38,050
32,529
27,930
28,509
31,088
30,882

30,882

31,088

28,509

27,930

32,529

38,050

38,971

46,039

47,605

45,481

43,271

43,578

43,161

42,373

45,052

23,997

24,385

27,484

28,584

25,281

25,414

24,529

24,590

25,866

25,016

25,630

29,852

30,197

27,097

29,513

28,893

25,502

26,487

25,538

29,339

29,297

29,332

29,795

30,321

35,767

37,500

36,789

28,474

26,987

23,049

17,419

13,837

13,695

9,628

6,377

5,732

6,429

4,881

5,940

5,643

5,556

7,042

6,371

5,452

7,139

6,806

5,210

4,987

4,842

6,143

5,893

5,206

4,779

4,160

3,150

3,271

5,416

5,398

5,914

5,950

4,278

3,953

4,145

4,502

3,873

3,626

3,427

3,588

3,408

3,791

3,744

3,462

2,222

1,469

1,191

1,099

792

727

900

600

700

500

600

500

1,700

1,500

> Total Current Liabilities

1,500
1,700
500
600
600
700
700
600
600
900
727
792
1,099
1,171
1,171
1,388
2,157
2,569
2,569
2,909
3,002
2,627
2,875
2,743
2,995
2,946
3,488
3,231
3,095
3,460
5,199
5,270
4,831
4,682
2,665
2,707
3,745
4,453
4,890
5,621
5,902
4,637
4,837
5,109
6,748
7,098
5,423
6,341
7,016
5,537
5,630
5,931
4,870
6,420
5,726
6,373
9,625
13,692
13,836
17,419
23,049
26,987
28,474
16,789
18,072
17,850
14,096
15,315
17,280
9,804
10,340
7,032
8,474
8,091
8,009
9,179
7,313
10,146
10,391
7,667
7,620
9,143
8,439
11,232
12,685
13,205
15,730
14,835
12,394
12,374
13,357
11,495
12,708
12,793
11,232
34,038
21,756
20,966
20,966
18,535
19,338
17,691
15,070
17,452
21,408
16,637

16,637

21,408

17,452

15,070

17,691

19,338

18,535

20,966

21,756

34,038

11,232

12,793

12,708

11,495

13,357

12,374

12,394

14,835

15,730

13,205

12,685

11,232

8,439

9,143

7,620

7,667

10,391

10,146

7,313

9,179

8,009

8,091

8,474

7,032

10,340

9,804

17,280

15,315

14,096

17,850

18,072

16,789

28,474

26,987

23,049

17,419

13,836

13,692

9,625

6,373

5,726

6,420

4,870

5,931

5,630

5,537

7,016

6,341

5,423

7,098

6,748

5,109

4,837

4,637

5,902

5,621

4,890

4,453

3,745

2,707

2,665

4,682

4,831

5,270

5,199

3,460

3,095

3,231

3,488

2,946

2,995

2,743

2,875

2,627

3,002

2,909

2,569

2,157

1,388

1,171

1,099

792

727

900

600

700

600

500

1,700

1,500

Short-term Debt

100
200
0
0
0
0
0
0
0
0
0
0
0
0
11
333
803
0
824
978
826
612
861
1,000
1,204
950
810
842
713
842
922
1,460
1,850
2,322
517
499
445
370
811
1,548
2,033
194
192
192
188
177
139
104
69
43
34
27
23
18
15
12
9
6
4
4
3
2
1
1
571
2,308
4,113
5,970
7,963
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,546
1,680
3,546
2,628
2,257
1,542
1,342
1,155
1,167
1,417
22,807
10,275
0
9,822
8,575
8,129
4,139
5,136
-38
8,198
2,183

2,183

8,198

-38

5,136

4,139

8,129

8,575

9,822

10,275

22,807

1,417

1,167

1,155

1,342

1,542

2,257

2,628

3,546

1,680

5,546

7,963

5,970

4,113

2,308

571

104

139

177

188

192

194

2,033

1,548

811

370

445

499

517

2,322

1,850

1,460

922

842

713

842

810

950

1,204

1,000

861

612

826

978

824

803

333

200

100

Short Long Term Debt

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,680
1,909
1,145
763
191
0
0
0
0
21,133
8,443
7,818
6,631
6,640
6,137
2,134
3,131
5,364
6,119
244

244

6,119

5,364

3,131

2,134

6,137

6,640

6,631

7,818

8,443

21,133

191

763

1,145

1,909

1,680

Accounts payable

1,000
1,000
400
500
400
500
500
400
300
500
407
527
684
741
741
810
1,095
1,159
1,159
1,644
1,797
1,681
1,697
1,454
1,468
1,667
2,237
2,037
1,936
2,125
2,624
1,865
1,503
1,795
1,618
1,566
2,425
2,920
3,363
3,256
2,972
2,983
3,418
3,195
3,977
5,211
3,834
5,020
4,219
3,389
3,769
3,442
2,843
3,660
2,701
3,219
3,609
5,365
4,662
6,411
8,091
14,834
16,100
8,304
7,112
8,686
5,133
6,277
5,171
5,295
5,138
4,320
5,223
3,995
4,420
4,976
3,397
5,858
3,944
3,870
4,189
4,222
4,012
3,207
6,931
4,492
4,522
4,065
3,194
3,018
3,123
3,313
4,190
4,155
3,307
4,932
4,834
3,739
3,739
2,942
3,051
4,053
5,202
5,927
3,929
4,516

4,516

3,929

5,927

5,202

4,053

3,051

2,942

3,739

4,834

4,932

3,307

4,155

4,190

3,313

3,123

3,018

3,194

4,065

4,522

4,492

6,931

3,207

4,012

4,222

4,189

3,870

3,944

5,858

3,397

4,976

4,420

3,995

5,223

4,320

5,138

5,295

5,171

6,277

5,133

8,686

7,112

8,304

16,100

14,834

8,091

6,411

4,662

5,365

3,609

3,219

2,701

3,660

2,843

3,442

3,769

3,389

4,219

5,020

3,834

5,211

3,977

3,195

3,418

2,983

2,972

3,256

3,363

2,920

2,425

1,566

1,618

1,795

1,503

1,865

2,624

2,125

1,936

2,037

2,237

1,667

1,468

1,454

1,697

1,681

1,797

1,644

1,159

1,095

810

741

684

527

407

500

300

400

500

400

500

400

1,000

Other Current Liabilities

400
500
100
100
200
200
200
200
300
400
320
265
415
419
419
579
1,062
586
1,410
1,265
1,205
946
1,178
1,289
1,527
1,279
1,251
1,194
1,159
1,335
1,225
3,405
1,078
34
145
81
387
48
86
15
46
337
198
362
331
245
209
156
923
251
511
630
103
165
202
3,000
115
96
9,043
10,794
14,685
12,016
12,289
8,456
10,125
6,648
4,606
2,785
3,817
4,326
4,863
2,583
2,937
3,831
3,495
4,123
3,825
4,210
6,231
3,585
3,232
4,716
4,192
5,571
3,391
850
7,039
4,851
4,286
4,810
6,366
4,627
5,110
5,144
4,203
3,993
4,371
3,111
5,090
4,660
5,887
7,702
4,359
11,266
9,208
9,892

9,892

9,208

11,266

4,359

7,702

5,887

4,660

5,090

3,111

4,371

3,993

4,203

5,144

5,110

4,627

6,366

4,810

4,286

4,851

7,039

850

3,391

5,571

4,192

4,716

3,232

3,585

6,231

4,210

3,825

4,123

3,495

3,831

2,937

2,583

4,863

4,326

3,817

2,785

4,606

6,648

10,125

8,456

12,289

12,016

14,685

10,794

9,043

115

3,000

202

165

103

630

511

251

923

156

209

245

331

362

198

337

387

145

1,078

3,405

1,225

1,335

1,159

1,194

1,251

1,279

1,527

1,289

1,178

946

1,205

1,265

1,410

586

1,062

579

419

415

265

320

400

300

200

100

500

400

> Long-term Liabilities

0
0
0
0
-100
0
0
0
0
0
0
0
0
20
20
81
65
0
893
835
790
782
713
684
631
926
1,014
914
858
819
751
644
566
734
607
443
415
326
316
272
241
205
149
101
58
41
29
30
26
19
14
9
12
9
6
4
3
2
1
1
0
0
0
20,000
19,429
17,917
16,225
14,481
12,052
19,493
18,999
18,506
18,013
17,411
20,884
20,334
19,784
20,052
19,460
17,962
17,396
16,723
16,151
13,297
12,729
12,076
12,854
12,650
11,990
11,623
31,694
30,878
30,453
30,785
32,039
11,443
25,849
25,073
25,073
20,436
18,712
14,838
12,860
11,057
9,680
14,245

14,245

9,680

11,057

12,860

14,838

18,712

20,436

25,073

25,849

11,443

32,039

30,785

30,453

30,878

31,694

11,623

11,990

12,650

12,854

12,076

12,729

13,297

16,151

16,723

17,396

17,962

19,460

20,052

19,784

20,334

20,884

17,411

18,013

18,506

18,999

19,493

12,052

14,481

16,225

17,917

19,429

20,000

101

149

205

241

272

316

326

415

443

607

734

566

644

751

819

858

914

1,014

926

631

684

713

782

790

835

893

-100

Long term Debt Total

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
3
2
1
1
0
0
0
20,000
19,429
17,917
16,225
14,481
12,052
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,684
20,764
20,856
0
21,041
0
0
0
0
0
0
0
6,147
4,740
0
0

4,740

6,147

21,041

20,856

20,764

20,684

12,052

14,481

16,225

17,917

19,429

20,000

Warrants

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,407
7,068
7,104
7,125
6,898
6,901
7,179
7,997
7,786
5,159
4,896
4,226
4,226
4,226
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

4,226

4,896

5,159

7,786

7,997

7,179

6,901

6,898

7,125

7,104

7,068

7,407

Other Liabilities

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
887
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,493
18,999
18,506
18,013
17,411
20,884
20,334
19,784
20,052
19,460
17,963
17,396
16,724
13,865
13,297
12,729
12,076
11,518
10,960
10,401
9,843
9,451
8,910
8,558
8,015
7,476
6,937
6,529
6,000
5,470
5,119
4,579
2,614
0
2,484
0
0

2,484

2,614

4,579

5,119

5,470

6,000

6,529

6,937

7,476

8,015

8,558

8,910

9,451

9,843

10,401

10,960

11,518

12,076

12,729

13,297

13,865

16,724

17,396

17,963

19,460

20,052

19,784

20,334

20,884

17,411

18,013

18,506

18,999

19,493

887

Deferred Long Term Liability

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,493
18,999
18,506
18,013
17,411
20,884
20,334
19,784
20,052
19,460
17,962
17,396
16,723
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

16,723

17,396

17,962

19,460

20,052

19,784

20,334

20,884

17,411

18,013

18,506

18,999

19,493

> Total Stockholder Equity

2,100
1,700
6,000
5,300
4,900
4,600
4,200
3,900
3,700
3,600
3,380
3,041
2,746
2,861
2,861
2,861
2,566
2,597
2,597
3,061
2,936
3,046
2,985
2,918
3,034
3,172
3,274
3,340
3,405
3,422
3,635
3,842
4,014
3,845
11,918
10,971
9,434
8,374
6,706
6,311
6,204
17,961
17,113
16,554
14,352
11,821
10,615
9,562
8,797
29,323
29,837
30,887
31,339
30,538
29,158
27,725
24,963
18,245
25,585
16,672
1,172
-9,962
-10,506
17,239
6,101
596
-3,527
-3,914
-5,460
68,703
67,822
65,988
64,429
62,320
60,205
57,630
55,757
52,956
50,605
43,846
40,790
32,913
27,367
16,889
12,670
27,277
20,161
29,592
23,703
20,320
21,774
16,212
42,075
34,170
26,178
18,203
11,094
2,535
2,535
20,145
16,136
14,106
12,542
9,389
21,518
21,291

21,291

21,518

9,389

12,542

14,106

16,136

20,145

2,535

11,094

18,203

26,178

34,170

42,075

16,212

21,774

20,320

23,703

29,592

20,161

27,277

12,670

16,889

27,367

32,913

40,790

43,846

50,605

52,956

55,757

57,630

60,205

62,320

64,429

65,988

67,822

68,703

-5,460

-3,914

-3,527

596

6,101

17,239

-10,506

-9,962

1,172

16,672

25,585

18,245

24,963

27,725

29,158

30,538

31,339

30,887

29,837

29,323

8,797

9,562

10,615

11,821

14,352

16,554

17,113

17,961

6,204

6,311

6,706

8,374

9,434

10,971

11,918

3,845

4,014

3,842

3,635

3,422

3,405

3,340

3,274

3,172

3,034

2,918

2,985

3,046

2,936

3,061

2,597

2,566

2,861

2,746

3,041

3,380

3,600

3,700

3,900

4,200

4,600

4,900

5,300

6,000

1,700

2,100

Common Stock

-1,100
-1,100
0
0
0
0
0
8,700
8,700
9,100
8,775
8,788
8,800
9,035
9,286
9,676
9,842
10,350
10,601
11,501
11,848
12,031
11,751
11,777
11,794
12,152
12,175
12,185
12,185
12,191
11,975
12,416
12,146
12,629
22,392
22,968
23,052
23,148
23,126
23,207
23,534
33,415
33,686
33,977
34,263
34,799
35,173
35,713
36,379
53,545
54,291
55,062
55,993
57,017
58,679
62,482
65,291
67,408
85,193
88,408
90,632
92,866
106,884
146,702
151,397
154,458
158,777
161,576
164,056
249,018
251,766
252,652
253,778
257,773
260,530
263,073
265,648
268,200
270,478
270,303
272,055
273,211
274,387
275,022
275,635
299,602
301,172
320,883
6
7
7
7
9
9
9
9
9
9
9
1
1
1
1
2
3
3

320,883

301,172

299,602

275,635

275,022

274,387

273,211

272,055

270,303

270,478

268,200

265,648

263,073

260,530

257,773

253,778

252,652

251,766

249,018

164,056

161,576

158,777

154,458

151,397

146,702

106,884

92,866

90,632

88,408

85,193

67,408

65,291

62,482

58,679

57,017

55,993

55,062

54,291

53,545

36,379

35,713

35,173

34,799

34,263

33,977

33,686

33,415

23,534

23,207

23,126

23,148

23,052

22,968

22,392

12,629

12,146

12,416

11,975

12,191

12,185

12,175

12,152

11,794

11,777

11,751

12,031

11,848

11,501

10,601

10,350

9,842

9,676

9,286

9,035

8,800

8,788

8,775

9,100

8,700

-1,100

Retained Earnings Total Equity

-393,814

-390,509

-353,558

-345,158

-337,406

-328,743

-321,393

-314,500

-306,516

-299,214

-291,359

-281,067

-272,388

-263,012

-258,043

-245,812

-240,262

-231,223

-226,166

-219,083

-214,341

-209,287

-204,724

-199,362

-194,538

-188,768

-186,354

-183,817

-180,118

-173,734

-169,766

-166,596

-158,791

-150,458

-137,250

-125,387

-110,007

-96,334

-78,458

-66,553

-55,986

-47,033

-41,992

Accumulated Other Comprehensive Income

-100
-100
-200
-200
-200
-400
-400
300
300
-600
251
251
251
-808
-808
251
251
-956
-956
289
-956
-1,323
306
306
320
-1,753
-1,753
-1,753
-1,753
-2,174
320
-2,174
286
1,415
14
-2,856
-2,856
-3,172
-3,172
-3,172
-3,172
3,038
-2,971
3,390
3,413
3,378
-3,843
0
0
-4,730
-4,730
0
0
-214
-198
-172
-363
-281
-180
-176
-27
-7,452
-7,452
0
4
32
66
51
-8
-198
-127
-310
-580
-915
-963
-720
-604
-903
-790
-291
-42
-35
-228
-90
47
63
56
68
73
52
51
46
49
57
53
52
56
0
52
49
54
163
156
137
68
-1

-1

137

156

163

-90

-228

-35

-42

-291

-790

-903

-604

-720

-963

-915

-580

-310

-127

-198

-8

-7,452

-27

-176

-180

-281

-363

-172

-198

-214

-4,730

-3,843

3,378

3,413

3,390

-2,971

3,038

-3,172

-2,856

1,415

286

-2,174

320

-2,174

-1,753

320

306

-1,323

-956

289

-956

251

-808

251

-600

300

-400

-200

-100

Capital Surplus

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
322,837
326,777
336,216
337,551
370,760
371,510
371,274
371,700
0
0
0
0
0
0
402,894
403,203
0
0

403,203

402,894

371,700

371,274

371,510

370,760

337,551

336,216

326,777

322,837

Treasury Stock

Other Stockholders Equity

3,700
3,700
8,700
8,500
8,600
9,300
9,300
800
4,500
500
933
933
1,047
0
808
1,059
1,059
0
956
1,245
956
1,323
1,629
1,629
1,644
1,753
1,753
1,753
1,753
2,174
2,494
2,174
2,460
4,271
22,392
2,856
25,908
26,320
26,298
26,380
26,706
39,425
39,787
40,338
40,647
42,020
3,514
3,635
3,727
65,911
62,088
7,959
8,224
70,947
66,612
69,717
71,996
81,083
92,138
95,130
97,505
14,631
7,997
7,786
5,163
13,045
4,292
4,277
4,218
8,601
-127
-310
420
85
37
280
396
97
210
-291
-42
9,335
-228
9,339
6,246
6,284
5,581
5,690
328,701
332,694
342,310
343,811
377,129
34,104
371,274
371,700
372,168
52
372,554
402,304
402,480
402,701
402,894
403,064
21,518
418,487

418,487

21,518

403,064

402,894

402,701

402,480

402,304

372,554

372,168

371,700

371,274

34,104

377,129

343,811

342,310

332,694

328,701

5,690

5,581

6,284

6,246

9,339

-228

9,335

-42

-291

210

396

280

420

-310

-127

8,601

4,218

4,277

4,292

13,045

5,163

7,786

7,997

14,631

97,505

95,130

92,138

81,083

71,996

69,717

66,612

70,947

8,224

7,959

62,088

65,911

3,727

3,635

3,514

42,020

40,647

40,338

39,787

39,425

26,706

26,380

26,298

26,320

25,908

2,856

22,392

4,271

2,460

2,174

2,494

2,174

1,753

1,644

1,629

1,323

956

1,245

956

1,059

808

1,047

933

500

4,500

800

9,300

8,600

8,500

8,700

3,700

Balance Sheet

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31
Accounts Payable	4,516	4,053	3,739	4,155	3,018	4,492	4,222	5,858	3,995	5,295	8,686	14,834	5,365	3,660	3,389	5,211	2,983	2,920	1,795	2,125	1,667	1,681	1,159	741	500	500	1,000
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income	-1	163	52	57	52	63	-35	-903	-915	-198	32	-7,452	-281	-214	-4,730	3,378	3,038	-3,172	1,415	-2,174	-1,753	-1,323	-956	-808	-600	-400	-100
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	4,902	6,674	7,891	2,988	3,274	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Stock	3	1	9	9	7	299,602	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Surpluse	0	0	0	371,510	326,777	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash	8,983	21,492	13,280	48,682	11,795	22,714	8,407	17,181	31,198	65,800	11,881	4,712	5,715	12,263	23,038	5,597	11,097	2,663	299	166	107	0	83	211	1,100	1,900	100
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash And Short Term Investments	10,935	21,492	22,438	58,679	26,045	33,532	33,055	57,940	70,681	85,728	23,916	4,712	17,526	24,202	23,038	5,597	11,097	2,663	299	166	107	0	83	211	1,100	1,900	100
Common Stock	3	1	9	9	7	299,602	273,211	268,200	257,773	249,018	154,458	92,866	67,408	8,276	53,545	34,799	33,415	23,148	12,629	12,191	12,152	12,031	10,601	9,286	9,100	0	-1,100
Common Stock Shares Outstanding	23,323	9,867	8,526	6,875	5,538	4,802	4,621	4,616	4,521	3,764	2,997	1,854	1,611	1,525	1,352	1,258	1,057	1,014	797	961	865	702	524	441	455	441	449
Common Stock Total Equity	0	0	0	9	7	299,602	273,211	268,200	257,773	249,018	154,458	92,866	67,408	0	0	0	0	0	12,629	12,191	12,152	12,031	10,601	9,286	9,100	0	0
Current Deferred Revenue	46	1,797	2,315	2,327	2,289	2,316	205	77	265	184	208	135	8,225	2,559	1,854	1,465	1,123	1,115	531	-842	-950	-612	-824	0	0	0	0
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Long Term Liab	0	0	0	0	0	0	16,723	20,052	17,411	19,493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Good Will	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	1,086	0	0	0
Intangible Assets	10,759	0	0	0	3	4	4	4	166	333	500	667	834	167	214	241	270	458	1,316	1,290	1,235	1,257	921	1,086	1,100	1,300	0
Inventory	5,871	5,814	4,076	3,913	3,647	4,039	7,637	12,141	7,872	3,920	2,800	2,650	2,504	2,937	3,088	3,162	2,559	2,660	2,052	1,652	1,350	1,477	1,067	585	400	0	300
Liabilities And Stockholders Equity	52,173	46,635	48,574	77,748	44,316	52,558	58,780	83,154	87,822	98,000	36,362	17,025	31,940	36,967	34,879	18,960	22,803	13,153	9,261	7,701	7,045	6,454	6,058	4,052	4,500	5,300	3,400
Long Term Debt	8,293	7,555	13,186	20,949	0	0	0	0	0	0	17,917	0	2	9	19	41	205	326	734	819	927	782	892	20	0	0	0
Long Term Debt Total	0	0	0	0	0	0	0	0	0	0	17,917	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Debt	4,456	-5,129	15,615	-24,745	-7,757	-22,714	-8,407	-17,181	-31,198	-65,800	8,344	-4,709	-5,706	-12,255	-22,976	-5,379	-10,698	-1,967	2,757	1,495	1,770	1,393	1,633	-180	-1,100	-1,900	100
Net Invested Capital	29,828	23,795	23,539	55,119	21,083	27,277	32,913	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Receivables	10,901	6,259	5,913	4,171	4,203	7,351	6,356	6,393	5,047	4,472	4,578	4,432	4,223	4,507	3,493	5,230	4,687	3,474	2,836	2,302	2,170	1,722	1,115	927	1,000	700	400
Net Tangible Assets	0	13,185	1,614	33,249	19,399	26,356	31,988	52,031	61,233	67,449	-825	-11,549	16,490	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Working Capital	12,133	17,619	14,322	56,676	24,500	33,621	39,685	68,364	76,535	84,903	14,068	-13,838	12,204	26,246	24,412	7,331	14,009	4,606	698	781	793	705	97	801	1,600	2,200	-800
Non Current Assets Total	23,403	11,325	13,286	8,279	7,443	5,733	9,951	4,644	3,196	3,293	4,444	3,876	6,043	4,301	4,930	4,531	4,157	4,094	3,881	3,460	3,306	3,122	3,392	2,081	2,000	2,400	2,500
Non Current Liabilities Other	14	14	14	1,821	11,623	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Current Liabilities Total	14,245	14,838	25,073	30,785	11,623	12,076	16,723	20,052	17,411	19,493	17,917	0	2	9	19	41	205	326	734	819	926	782	893	20	0	0	0
Non Currrent Assets Other	705	1,799	2,142	1,805	876	2,174	6,478	2,328	463	542	1,375	430	1,998	164	164	121	126	128	135	121	127	135	755	171	200	200	1,800
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	0	13,818	2,142	4,716	876	2,174	6,482	2,328	463	542	1,374	430	1,998	164	164	121	126	128	135	120	128	135	755	171	0	0	0
Other Current Assets	1,063	1,745	2,861	2,706	2,980	1,904	1,780	2,035	1,027	587	624	1,356	1,644	1,021	330	441	303	261	193	112	104	118	108	249	0	300	100
Other Current Liab	9,892	7,702	5,090	5,144	4,810	850	4,716	4,210	3,831	4,326	6,648	12,016	96	184	251	245	337	48	34	1,335	1,279	946	1,410	419	400	200	500
Other Liab	0	2,614	6,000	8,015	9,843	12,076	16,723	20,052	17,411	19,493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Stockholder Equity	418,487	402,701	372,554	371,510	326,777	6,284	9,335	97	85	8,601	13,045	14,631	81,083	70,947	65,911	42,020	39,425	26,320	4,271	2,174	1,753	1,323	956	808	500	9,300	3,700
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Property Plant And Equipment Gross	19,822	16,241	17,326	2,642	5,646	2,638	2,549	1,392	1,647	1,497	1,649	1,858	2,290	3,050	3,632	3,249	2,840	2,588	2,430	2,049	1,943	1,731	1,716	824	700	900	700
Property Plant And Equipment Net	11,018	8,605	10,223	5,553	5,646	2,638	2,549	1,392	1,647	1,497	1,649	1,858	2,290	3,050	3,632	3,249	2,840	2,588	2,430	2,049	1,943	1,731	1,716	824	700	900	700
Property Plant Equipment	0	8,605	10,223	5,553	2,874	4,275	8,536	3,218	1,647	1,497	1,649	1,858	2,290	3,049	3,631	3,249	2,840	2,588	2,430	2,049	1,943	1,731	1,716	824	0	0	0
Retained Earnings	-397,198	-388,759	-370,080	-337,406	-306,516	-272,388	-240,262	-214,341	-194,538	-180,118	-158,791	-110,007	-55,986	-34,541	-31,858	-26,357	-18,492	-14,774	-10,199	-8,769	-8,980	-8,985	-8,004	-6,425	-5,400	-4,300	-1,900
Retained Earnings Total Equity	0	0	0	-337,406	-306,516	-272,388	-240,262	-214,341	-194,538	-180,118	-158,791	-110,007	-55,986	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt	244	2,134	7,818	0	763	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Short Long Term Debt Total	13,439	16,363	28,895	23,937	4,037	0	0	0	0	0	20,225	2	9	9	62	218	399	696	3,056	1,661	1,876	1,394	1,716	30	0	0	200
Short Term Debt	2,183	4,139	9,822	1,167	2,257	5,546	0	0	0	0	2,308	2	6	18	43	177	194	370	2,322	842	950	612	824	11	0	0	200
Short Term Investments	1,952	11,390	9,158	9,997	14,250	10,818	24,648	40,760	39,483	19,927	12,035	0	11,811	11,938	0	0	0	0	0	9	9	14	293	150	0	0	0
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Assets	52,173	46,635	48,574	77,748	44,316	52,558	58,780	83,154	87,822	98,000	36,362	17,025	31,940	36,967	34,879	18,960	22,803	13,153	9,261	7,701	7,045	6,454	6,058	4,052	4,500	5,300	3,400
Total Current Assets	28,770	35,310	35,288	69,469	36,874	46,825	48,828	78,509	84,626	94,707	31,918	13,149	25,897	32,666	29,949	14,429	18,646	9,059	5,380	4,241	3,739	3,331	2,666	1,971	2,500	2,900	900
Total Current Liabilities	16,637	17,691	20,966	12,793	12,374	13,205	9,143	10,146	8,091	9,804	17,850	26,987	13,692	6,420	5,537	7,098	4,637	4,453	4,682	3,460	2,946	2,627	2,569	1,171	900	700	1,700
Total Liab	30,882	32,529	46,039	43,578	23,997	25,281	25,866	30,197	25,502	29,297	35,767	26,987	13,695	6,429	5,556	7,139	4,842	4,779	5,416	4,278	3,873	3,408	3,462	1,191	900	700	1,700
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Stockholder Equity	21,291	14,106	2,535	34,170	20,320	27,277	32,913	52,956	62,320	68,703	596	-9,962	18,245	30,538	29,323	11,821	17,961	8,374	3,845	3,422	3,172	3,046	2,597	2,861	3,600	4,600	1,700
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Warrants	0	0	0	0	0	0	0	0	0	0	4,896	7,179	7,104	0	0	0	0	0	0	0	0	0	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31	1997-09-30
Accounts Payable	4,516	3,929	5,927	5,202	4,053	3,051	2,942	3,739	3,739	4,834	4,932	3,307	4,155	4,190	3,313	3,123	3,018	3,194	4,065	4,522	4,492	6,931	3,207	4,012	4,222	4,189	3,870	3,944	5,858	3,397	4,976	4,420	3,995	5,223	4,320	5,138	5,295	5,171	6,277	5,133	8,686	7,112	8,304	16,100	14,834	8,091	6,411	4,662	5,365	3,609	3,219	2,701	3,660	2,843	3,442	3,769	3,389	4,219	5,020	3,834	5,211	3,977	3,195	3,418	2,983	2,972	3,256	3,363	2,920	2,425	1,566	1,618	1,795	1,503	1,865	2,624	2,125	1,936	2,037	2,237	1,667	1,468	1,454	1,697	1,681	1,797	1,644	1,159	1,159	1,095	810	741	741	684	527	407	500	300	400	500	500	400	500	400	1,000	1,000
Accumulated Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Depreciation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Accumulated Other Comprehensive Income	-1	68	137	156	163	54	49	52	0	56	52	53	57	49	46	51	52	73	68	56	63	47	-90	-228	-35	-42	-291	-790	-903	-604	-720	-963	-915	-580	-310	-127	-198	-8	51	66	32	4	0	-7,452	-7,452	-27	-176	-180	-281	-363	-172	-198	-214	0	0	-4,730	-4,730	0	0	-3,843	3,378	3,413	3,390	-2,971	3,038	-3,172	-3,172	-3,172	-3,172	-2,856	-2,856	14	1,415	286	-2,174	320	-2,174	-1,753	-1,753	-1,753	-1,753	320	306	306	-1,323	-956	289	-956	-956	251	251	-808	-808	251	251	251	-600	300	300	-400	-400	-200	-200	-200	-100	-100
Additional Paid In Capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Lease Obligations	4,902	5,427	5,934	6,169	6,674	7,163	6,882	7,383	7,891	7,058	6,180	4,939	2,988	2,194	2,546	2,911	3,274	3,072	3,328	3,017	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	2	3	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Stock	3	3	2	1	1	1	1	1	9	9	9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Capital Surpluse	0	0	403,203	402,894	0	0	0	0	0	0	371,700	371,274	371,510	370,760	337,551	336,216	326,777	322,837	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Cash	8,983	7,759	8,959	10,894	21,492	12,980	30,780	13,280	13,280	23,390	32,378	35,675	48,682	56,614	26,697	37,400	11,795	14,421	21,417	20,920	22,714	4,292	1,748	3,278	8,407	3,888	8,328	11,900	17,181	19,293	23,822	30,008	31,198	33,173	37,146	63,333	65,800	3,017	2,859	661	11,881	21,213	40,952	5,774	4,712	1,174	6,470	13,639	5,715	8,422	9,318	7,952	12,263	23,657	24,200	24,634	23,038	2,768	3,335	3,353	5,597	7,482	9,736	10,641	11,097	0	0	2,663	2,663	4,035	4,748	5,695	299	451	1,276	866	166	62	306	369	107	213	28	50	0	59	12	83	83	0	28	211	211	446	480	836	1,100	1,000	1,100	1,300	1,900	2,100	2,500	3,500	100	100
Cash And Equivalents	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Cash And Short Term Investments	10,935	11,730	8,959	16,834	21,492	27,564	30,780	22,438	0	33,203	40,952	46,139	58,679	67,316	39,955	48,856	26,045	28,997	35,233	27,796	33,532	17,702	22,685	28,100	33,055	38,917	43,242	52,740	57,940	57,728	64,434	69,443	70,681	72,991	77,261	83,330	85,728	12,034	11,935	14,730	23,916	31,218	40,952	5,774	4,712	11,252	20,386	25,551	17,526	20,236	21,457	19,987	24,202	23,657	24,200	24,634	23,038	2,768	3,335	3,353	5,597	7,482	9,736	10,641	11,097	0	0	0	2,663	4,035	4,748	5,695	299	451	1,276	866	166	62	306	369	107	213	28	50	0	59	12	83	0	150	28	211	0	446	480	836	1,100	1,000	1,100	1,300	1,900	2,100	2,500	3,500	100	100
Common Stock	3	3	2	1	1	1	1	9	9	9	9	9	9	9	7	7	7	6	320,883	301,172	299,602	275,635	275,022	274,387	273,211	272,055	270,303	270,478	268,200	265,648	263,073	260,530	257,773	253,778	252,652	251,766	249,018	164,056	161,576	158,777	154,458	151,397	146,702	106,884	92,866	90,632	88,408	85,193	67,408	65,291	62,482	58,679	57,017	55,993	55,062	54,291	53,545	36,379	35,713	35,173	34,799	34,263	33,977	33,686	33,415	23,534	23,207	23,126	23,148	23,052	22,968	22,392	12,629	12,146	12,416	11,975	12,191	12,185	12,185	12,175	12,152	11,794	11,777	11,751	12,031	11,848	11,501	10,601	10,350	9,842	9,676	9,286	9,035	8,800	8,788	8,775	9,100	8,700	8,700	0	0	0	0	0	-1,100	-1,100
Common Stock Shares Outstanding	28,652	27,521	18,497	18,360	11,550	10,528	8,805	8,535	93,986	8,535	8,518	8,509	6,528	6,528	6,312	6,138	5,859	5,800	5,292	5,191	5,095	4,663	4,663	4,663	4,565	4,660	4,639	4,608	4,595	4,607	4,607	4,607	4,371	4,566	4,552	4,515	4,515	3,673	3,603	3,619	3,607	3,575	2,838	1,931	1,931	1,890	1,870	1,779	1,779	1,637	1,587	1,573	1,573	1,558	1,691	1,789	1,789	1,278	1,272	1,271	1,271	1,258	1,257	1,222	1,222	984	1,047	1,069	1,053	1,053	1,055	876	710	710	777	993	593	593	1,119	1,118	772	772	772	772	733	733	710	579	6,826	579	513	441	4,855	441	441	441	545	545	769	769	455	455	778	778	778	778
Common Stock Total Equity	0	0	2	1	0	0	0	0	0	0	9	9	9	9	7	7	7	6	320,883	301,172	299,602	275,635	275,022	274,387	273,211	272,055	270,303	270,478	268,200	265,648	263,073	260,530	257,773	253,778	252,652	251,766	249,018	164,056	161,576	158,777	154,458	151,397	146,702	106,884	92,866	90,632	88,408	85,193	67,408	65,291	62,482	0	0	0	0	0	0	0	35,713	35,173	0	0	0	0	0	0	0	0	0	0	22,968	0	12,629	12,146	12,416	11,975	12,191	12,185	12,185	12,175	12,152	11,794	11,777	11,751	12,031	11,848	11,501	10,601	10,601	9,842	9,676	9,353	9,286	8,800	8,788	8,775	9,100	8,700	8,700	0	0	0	0	0	0	-
Current Deferred Revenue	46	73	297	373	1,797	2,271	2,358	2,315	0	2,276	2,306	2,305	2,327	2,253	2,213	2,326	2,289	2,287	2,372	2,488	2,316	2,363	2,454	235	205	199	212	217	77	91	80	94	265	313	130	339	184	329	284	244	208	264	29	83	135	271	210	127	8,225	5,892	142	2,807	2,577	1,900	1,831	1,315	1,854	1,805	1,061	1,241	1,465	2,252	1,359	1,029	1,123	852	802	629	1,115	489	561	385	531	400	-1,460	428	-842	-713	-842	-810	-950	-1,204	-1,000	-861	-612	-826	-978	-824	0	-803	-333	-225	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Deferred Long Term Asset Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Deferred Long Term Liab	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16,723	17,396	17,962	19,460	20,052	19,784	20,334	20,884	17,411	18,013	18,506	18,999	19,493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Earning Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Good Will	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	921	962	1,003	0	1,086	0	0	0	0	0	0	0	0	0	0	0	0	-
Intangible Assets	10,759	10,897	0	2,326	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	921	921	4	4	4	4	4	4	43	82	124	166	207	249	291	333	374	416	458	500	541	583	625	667	709	750	792	834	840	153	160	167	191	199	206	214	230	235	235	241	248	256	263	270	429	434	446	458	468	450	407	1,316	1,321	1,325	1,282	1,290	1,290	1,223	1,229	1,235	1,241	1,245	1,251	1,257	1,263	347	921	921	0	0	1,086	1,086	1,001	1,040	1,079	1,100	0	1,200	1,200	1,300	1,300	1,400	1,400	0	1,500
Inventory	5,871	5,486	5,814	5,595	5,814	5,020	5,171	4,076	4,076	4,028	4,677	4,117	3,913	3,877	4,557	4,293	3,647	3,583	3,973	4,002	4,039	4,647	4,520	8,545	7,637	14,865	13,774	13,421	12,141	11,760	11,010	9,164	7,872	7,415	6,315	5,196	3,920	2,982	2,784	2,910	2,800	2,814	2,917	2,866	2,650	2,672	2,762	2,410	2,504	2,235	2,358	2,782	2,937	2,535	2,863	2,546	3,088	2,675	2,813	2,816	3,162	3,167	2,712	2,672	2,559	2,794	2,821	2,657	2,660	2,547	2,545	2,212	2,052	2,063	2,380	2,650	1,652	1,438	1,433	1,611	1,350	1,355	1,570	1,531	1,477	2,069	2,160	1,067	1,067	808	656	585	585	526	603	579	400	400	300	300	0	200	300	300	300	400
Liabilities And Stockholders Equity	52,173	52,606	37,898	40,472	46,635	54,186	59,116	48,574	0	58,699	63,684	69,449	77,748	85,236	58,585	66,826	44,316	48,087	57,076	48,745	52,558	38,084	41,418	51,957	58,780	65,806	69,476	80,457	83,154	82,854	87,143	89,098	87,822	90,916	91,526	97,161	98,000	23,872	25,882	26,794	36,362	43,601	54,028	17,968	17,025	24,221	34,091	39,423	31,940	34,590	34,102	34,890	36,967	36,220	36,827	35,480	34,879	15,839	15,933	16,067	18,960	21,159	21,764	22,100	22,803	12,347	12,204	11,911	13,153	13,593	14,121	15,190	9,261	9,412	9,756	9,585	7,701	7,358	7,484	7,776	7,045	6,660	6,345	6,573	6,454	6,727	6,804	6,058	6,058	4,788	4,330	4,052	4,052	3,845	3,833	4,107	4,500	4,300	4,500	4,900	5,300	5,400	5,900	6,500	3,400	3,600
Long Term Debt	8,293	3,331	4,740	6,147	7,555	8,962	10,370	11,778	13,186	14,094	0	21,041	20,949	20,856	20,764	20,684	0	0	0	1,336	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12,052	14,481	16,225	17,917	19,429	20,000	0	0	0	1	1	2	2	4	6	9	11	9	13	19	26	30	29	41	59	101	150	205	241	272	315	326	415	443	607	734	567	644	751	819	858	914	1,014	927	631	684	713	782	789	834	0	892	65	81	115	20	0	0	0	0	0	0	0	0	0	0	0	0	-
Long Term Debt Total	0	0	4,740	6,147	0	0	0	0	0	0	0	21,041	0	20,856	20,764	20,684	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12,052	14,481	16,225	17,917	19,429	20,000	0	0	0	1	1	2	3	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Long Term Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Negative Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Debt	4,456	7,118	-3,025	4,553	-5,129	9,282	-6,888	15,615	7,724	6,205	-5,065	-9,695	-24,745	-33,564	-3,386	-13,614	-7,757	-10,205	-16,181	-17,903	-21,864	8,437	11,549	10,587	-8,407	-3,888	-8,328	-11,900	-17,181	-19,293	-23,822	-30,008	-31,198	-33,173	-37,146	-63,333	-65,800	16,998	17,591	19,676	8,344	-1,213	-20,951	-5,773	-4,709	-1,171	-6,466	-13,634	-5,706	-8,410	-9,302	-7,932	-12,236	-23,622	-24,163	-24,586	-22,976	-2,673	-3,201	-3,185	-5,379	-7,236	-9,442	-10,300	-10,698	2,274	1,820	1,127	-1,967	-3,175	-3,806	-4,571	2,757	1,964	827	806	1,495	1,509	1,450	1,455	1,770	1,621	1,656	1,523	1,393	766	1,801	1,633	1,633	803	386	-180	-180	-446	-480	-836	-1,100	-1,000	-1,100	-1,300	-1,900	-2,100	-2,500	-3,500	100	-
Net Invested Capital	29,828	30,968	19,632	21,820	23,795	31,235	37,155	13,602	23,539	33,631	39,336	47,219	55,119	62,931	36,976	42,649	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Receivables	10,901	9,361	5,411	6,021	6,259	7,367	8,090	5,913	5,913	6,036	5,357	6,597	4,171	4,129	3,565	4,587	4,203	5,122	5,389	6,711	7,351	8,082	5,854	5,994	6,356	5,374	4,881	7,250	6,393	8,031	7,590	6,224	5,047	5,896	3,939	4,666	4,472	4,190	6,389	4,100	4,578	4,222	4,576	4,462	4,432	4,319	4,356	4,215	4,223	4,258	4,497	4,688	4,507	4,637	4,598	2,971	3,493	5,086	4,745	4,869	5,230	5,357	4,352	4,145	4,687	4,918	4,684	4,545	3,474	2,749	2,477	3,064	2,836	2,702	2,383	2,497	2,302	2,303	2,226	2,134	2,170	2,037	1,606	1,823	1,722	1,217	1,213	1,115	1,115	1,121	978	927	927	995	874	743	1,000	800	800	1,000	700	700	600	400	400	500
Net Tangible Assets	0	0	9,528	12,542	13,185	15,215	19,224	-5,728	1,614	10,173	17,282	26,178	33,249	42,075	15,291	20,853	19,399	22,782	28,671	19,240	26,356	11,749	15,968	26,692	31,988	39,865	42,921	49,680	52,031	54,794	56,627	59,160	61,233	63,301	64,818	66,610	67,449	-6,755	-5,251	-4,906	-825	4,639	15,735	-12,051	-11,549	-458	15,001	23,873	16,490	23,202	26,652	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Net Working Capital	12,133	6,765	10,113	14,620	17,619	23,020	28,710	5,202	14,322	24,326	18,361	48,010	56,676	65,235	40,041	46,136	24,500	28,170	33,428	24,460	33,621	19,408	24,299	35,807	39,685	53,568	56,137	64,359	68,364	72,471	74,798	77,753	76,535	79,430	81,408	83,666	84,903	2,614	6,382	8,246	14,068	20,870	32,471	-14,286	-13,838	-3,045	11,979	20,005	12,204	18,477	23,894	22,410	26,246	26,803	26,182	24,969	24,412	4,034	4,961	6,100	7,331	9,792	12,150	12,978	14,009	2,128	2,178	2,640	4,606	5,843	7,536	8,616	698	1,062	1,016	1,018	781	862	875	782	793	735	605	651	705	499	628	97	97	33	526	801	801	982	1,260	1,509	1,600	1,700	1,800	1,900	2,200	2,400	2,900	3,800	-800	-
Non Current Assets Total	23,403	24,433	10,472	10,782	11,325	11,828	11,871	13,286	13,286	12,617	11,285	10,207	8,279	7,293	7,049	7,332	7,443	7,523	8,814	8,556	5,733	5,991	5,887	7,711	9,951	4,619	5,671	5,707	4,644	3,071	3,166	3,335	3,196	3,012	3,086	3,155	3,293	3,978	4,185	4,451	4,444	4,660	4,768	3,780	3,876	4,217	4,694	5,582	6,043	6,489	3,836	6,754	4,301	4,548	4,714	4,881	4,930	4,790	4,630	4,543	4,531	4,619	4,505	4,284	4,157	4,317	4,404	4,382	4,094	4,005	3,878	3,909	3,881	3,518	3,470	3,368	3,460	3,401	3,379	3,507	3,306	2,930	2,997	3,047	3,122	3,227	3,268	3,392	0	2,598	2,416	2,081	2,081	1,763	1,780	1,871	2,000	2,000	2,100	2,300	2,400	2,400	2,400	2,200	2,500	2,600
Non Current Liabilities Other	14	14	6,317	14	14	14	14	14	14	0	0	0	1,821	0	0	0	11,623	0	0	1,336	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Non Current Liabilities Total	14,245	9,680	11,057	12,860	14,838	18,712	20,436	25,073	25,073	25,849	11,443	32,039	30,785	30,453	30,878	31,694	11,623	11,990	12,650	12,854	12,076	12,729	13,297	16,151	16,723	17,396	17,962	19,460	20,052	19,784	20,334	20,884	17,411	18,013	18,506	18,999	19,493	12,052	14,481	16,225	17,917	19,429	20,000	0	0	0	1	1	2	3	4	6	9	12	9	14	19	26	30	29	41	58	101	149	205	241	272	316	326	415	443	607	734	566	644	751	819	858	914	1,014	926	631	684	713	782	790	835	893	0	65	81	20	20	0	0	0	0	0	0	0	0	-100	0	0	0	-
Non Currrent Assets Other	705	705	243	1,798	1,799	1,715	1,990	2,142	2,142	2,255	1,750	1,954	1,805	1,488	1,382	1,184	876	1,084	2,000	2,056	2,174	2,402	2,360	4,214	6,478	1,985	3,217	3,362	2,328	601	601	601	463	542	542	542	542	1,068	1,198	1,311	1,375	1,492	1,524	442	430	647	988	1,736	1,998	2,269	164	2,832	164	164	164	165	164	148	148	123	121	117	149	149	126	126	126	126	128	130	132	134	135	129	117	119	121	123	125	126	127	129	131	133	135	166	168	755	755	311	283	171	171	119	95	120	200	1,200	100	200	200	200	100	100	1,800	400
Noncontrolling Interest In Consolidated Entity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Assets	0	0	1,803	0	13,818	14,794	1,990	2,141	2,142	2,255	1,750	1,954	4,716	3,587	1,382	1,184	876	1,084	2,000	2,056	2,174	2,402	2,360	6,498	7,403	2,909	4,142	4,287	3,253	1,565	1,604	1,646	1,549	1,670	1,712	1,754	1,796	2,363	2,535	2,690	2,795	2,954	3,028	1,988	2,018	2,277	2,659	3,449	3,753	4,029	1,238	3,912	1,252	1,276	1,284	1,292	1,299	1,299	1,304	1,280	1,282	1,286	1,326	1,333	1,317	1,476	1,481	1,492	1,506	1,518	1,503	1,461	1,451	1,450	1,442	1,402	1,411	1,413	1,347	1,355	1,363	1,370	1,376	1,385	1,392	1,429	1,435	1,492	1,676	1,273	1,286	1,247	1,257	1,120	1,135	1,199	0	0	0	0	0	0	0	0	0	-
Other Current Assets	1,063	1,596	21,751	1,240	1,745	2,407	3,204	2,861	0	2,815	1,413	2,389	2,706	2,621	3,458	1,758	2,980	2,862	3,668	1,681	1,904	1,662	2,472	1,607	1,780	2,032	1,907	1,339	2,035	2,265	943	932	1,027	1,601	926	814	587	688	589	602	624	687	815	1,086	1,356	1,761	1,893	1,664	1,644	1,373	1,955	678	1,021	844	451	448	330	521	409	485	441	535	459	357	303	318	294	328	261	258	473	309	193	669	239	195	112	146	132	147	104	110	129	106	118	141	144	108	108	111	102	249	99	114	95	80	0	100	200	0	300	0	100	100	100	-
Other Current Liab	9,892	9,208	11,266	4,359	7,702	5,887	4,660	5,090	3,111	4,371	3,993	4,203	5,144	5,110	4,627	6,366	4,810	4,286	4,851	7,039	850	3,391	5,571	4,192	4,716	3,232	3,585	6,231	4,210	3,825	4,123	3,495	3,831	2,937	2,583	4,863	4,326	3,817	2,785	4,606	6,648	10,125	8,456	12,289	12,016	14,685	10,794	9,043	96	115	3,000	202	165	103	630	511	251	923	156	209	245	331	362	198	337	46	15	86	48	387	81	145	34	1,078	3,405	1,225	1,335	1,159	1,194	1,251	1,279	1,527	1,289	1,178	946	1,205	1,265	1,410	586	1,062	579	419	419	415	265	320	400	300	200	200	200	200	100	100	500	400
Other Liab	0	0	2,484	0	2,614	4,579	5,119	5,470	6,000	6,529	6,937	7,476	8,015	8,558	8,910	9,451	9,843	10,401	10,960	11,518	12,076	12,729	13,297	13,865	16,724	17,396	17,963	19,460	20,052	19,784	20,334	20,884	17,411	18,013	18,506	18,999	19,493	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	887	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Other Stockholder Equity	418,487	21,518	403,064	402,894	402,701	402,480	402,304	372,554	52	372,168	371,700	371,274	34,104	377,129	343,811	342,310	332,694	328,701	5,690	5,581	6,284	6,246	9,339	-228	9,335	-42	-291	210	97	396	280	37	85	420	-310	-127	8,601	4,218	4,277	4,292	13,045	5,163	7,786	7,997	14,631	97,505	95,130	92,138	81,083	71,996	69,717	66,612	70,947	8,224	7,959	62,088	65,911	3,727	3,635	3,514	42,020	40,647	40,338	39,787	39,425	26,706	26,380	26,298	26,320	25,908	2,856	22,392	4,271	2,460	2,174	2,494	2,174	1,753	1,753	1,753	1,753	1,644	1,629	1,629	1,323	956	1,245	956	0	1,059	1,059	808	0	1,047	933	933	500	4,500	800	9,300	9,300	8,600	8,500	8,700	3,700	3,700
Preferred Stock Redeemable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Preferred Stock Total Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Property Plant And Equipment Gross	19,822	20,299	2,093	2,179	16,241	16,675	0	0	0	0	8,614	7,332	2,642	4,884	4,747	5,228	5,646	5,518	5,893	5,578	2,638	2,668	2,606	2,573	2,549	1,709	1,530	1,420	1,392	1,506	1,562	1,690	1,647	1,342	1,373	1,401	1,497	1,615	1,650	1,761	1,649	1,705	1,740	1,792	1,858	1,941	2,034	2,133	2,290	2,459	2,598	2,842	3,050	3,273	3,431	3,589	3,632	3,491	3,326	3,264	3,249	3,333	3,180	2,952	2,840	2,842	2,924	2,889	2,588	2,487	2,375	2,448	2,430	2,068	2,028	1,967	2,049	1,988	2,031	2,152	1,943	1,560	1,621	1,663	1,731	1,798	1,832	1,716	1,716	1,325	1,130	839	824	644	645	671	700	800	800	900	900	900	900	700	700	700
Property Plant And Equipment Net	11,018	11,910	9,308	5,737	8,605	9,192	8,960	10,223	0	9,441	8,614	7,332	5,553	4,884	4,747	5,228	5,646	5,518	5,893	5,578	2,638	2,668	2,606	2,573	2,549	1,709	1,530	1,420	1,392	1,506	1,562	1,690	1,647	1,342	1,373	1,401	1,497	1,615	1,650	1,761	1,649	1,705	1,740	1,792	1,858	1,941	2,034	2,133	2,290	2,459	2,598	2,842	3,050	3,273	3,431	3,589	3,632	3,491	3,326	3,264	3,249	3,333	3,180	2,952	2,840	2,842	2,924	2,889	2,588	2,487	2,375	2,448	2,430	2,068	2,028	1,967	2,049	1,988	2,031	2,152	1,943	1,560	1,621	1,663	1,731	1,798	1,832	1,716	0	1,325	1,130	824	0	644	645	671	700	800	800	900	900	900	900	700	700	700
Property Plant Equipment	0	0	2,093	2,179	8,605	9,192	8,960	9,577	10,223	9,441	8,614	2,472	5,553	2,785	3,127	3,053	2,874	3,034	4,008	4,074	4,275	4,534	4,472	8,580	8,536	3,203	4,256	4,258	3,218	1,506	1,562	1,690	1,647	1,342	1,373	1,401	1,497	1,615	1,650	1,761	1,649	1,705	1,740	1,792	1,858	1,941	2,034	2,133	2,290	2,459	2,598	2,842	3,049	3,272	3,431	3,589	3,631	3,491	3,326	3,264	3,249	3,333	3,179	2,952	2,840	2,841	2,924	2,889	2,588	2,487	2,375	2,447	2,430	2,068	2,028	1,966	2,049	1,988	2,031	2,151	1,943	1,560	1,621	1,663	1,731	1,797	1,832	1,916	1,716	1,325	1,130	839	824	644	645	671	0	0	0	0	0	0	0	0	0	-
Retained Earnings	-397,198	-395,686	-393,814	-390,509	-388,759	-386,399	-382,209	-370,080	-370,080	-361,139	-353,558	-345,158	-337,406	-328,743	-321,393	-314,500	-306,516	-299,214	-291,359	-281,067	-272,388	-263,012	-258,043	-246,792	-240,262	-231,223	-226,166	-219,083	-214,341	-209,287	-204,724	-199,362	-194,538	-188,768	-186,354	-183,817	-180,118	-173,734	-169,766	-166,596	-158,791	-150,458	-137,250	-125,387	-110,007	-96,334	-78,458	-66,553	-55,986	-47,033	-41,992	-37,453	-34,541	-32,878	-32,135	-32,251	-31,858	-31,308	-29,787	-28,072	-26,357	-23,324	-20,813	-19,703	-18,492	-17,330	-16,897	-16,420	-14,774	-13,619	-11,997	-10,488	-10,199	-8,418	-8,574	-8,660	-8,769	-8,780	-8,845	-8,900	-8,980	-9,080	-9,165	-9,072	-8,985	-8,912	-8,729	-8,004	-8,004	-7,527	-7,067	-6,425	-6,425	-6,305	-5,998	-5,647	-5,400	-5,300	-5,100	-4,700	-4,300	-3,500	-3,000	-2,500	-1,900	-1,500
Retained Earnings Total Equity	0	0	-393,814	-390,509	0	0	0	0	0	0	-353,558	-345,158	-337,406	-328,743	-321,393	-314,500	-306,516	-299,214	-291,359	-281,067	-272,388	-263,012	-258,043	-245,812	-240,262	-231,223	-226,166	-219,083	-214,341	-209,287	-204,724	-199,362	-194,538	-188,768	-186,354	-183,817	-180,118	-173,734	-169,766	-166,596	-158,791	-150,458	-137,250	-125,387	-110,007	-96,334	-78,458	-66,553	-55,986	-47,033	-41,992	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt	244	6,119	5,364	3,131	2,134	6,137	6,640	6,631	7,818	8,443	21,133	0	0	0	0	191	763	1,145	1,909	1,680	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Short Long Term Debt Total	13,439	14,877	5,934	15,447	16,363	22,262	23,892	28,895	0	29,595	27,313	25,980	23,937	23,050	23,311	23,786	4,037	4,217	5,236	3,017	850	12,729	13,297	13,865	0	0	0	0	0	0	0	0	0	0	0	0	0	20,015	20,450	20,338	20,225	20,000	20,001	1	2	3	4	6	9	12	16	21	27	35	37	48	62	95	134	168	218	246	294	342	399	2,274	1,820	1,127	696	859	942	1,124	3,056	2,416	2,103	1,673	1,661	1,571	1,756	1,824	1,876	1,835	1,684	1,574	1,394	826	1,813	1,716	1,716	803	414	30	30	0	0	0	0	0	0	0	0	0	0	0	200	100
Short Term Debt	2,183	8,198	-38	5,136	4,139	8,129	8,575	9,822	0	10,275	22,807	1,417	1,167	1,155	1,342	1,542	2,257	2,628	3,546	1,680	5,546	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7,963	5,970	4,113	2,308	571	1	1	2	3	4	4	6	9	12	15	18	23	27	34	43	69	104	139	177	188	192	192	194	2,033	1,548	811	370	445	499	517	2,322	1,850	1,460	922	842	713	842	810	950	1,204	1,000	861	612	826	978	824	0	803	333	11	0	0	0	0	0	0	0	0	0	0	0	0	200	100
Short Term Investments	1,952	3,971	5,906	5,940	11,390	14,584	0	9,158	9,158	9,813	8,574	10,464	9,997	10,702	13,258	11,456	14,250	14,576	13,816	6,876	10,818	13,410	20,937	24,822	24,648	35,029	34,914	40,841	40,760	38,434	40,612	39,436	39,483	39,818	40,115	19,998	19,927	9,017	9,076	14,068	12,035	10,005	0	0	0	10,078	13,916	11,911	11,811	11,814	12,139	12,035	11,938	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9	0	0	0	9	0	0	0	14	0	0	0	293	0	0	0	150	0	0	0	0	0	0	0	0	0	0	0	0	-
Temporary Equity Redeemable Noncontrolling Interests	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Assets	52,173	52,606	38,037	40,472	46,635	54,186	59,116	48,574	48,574	58,699	63,684	69,449	77,748	85,236	58,585	66,826	44,316	48,087	57,076	48,745	52,558	38,084	41,418	51,957	58,780	65,806	69,476	80,457	83,154	82,854	87,143	89,098	87,822	90,916	91,526	97,161	98,000	23,872	25,882	26,794	36,362	43,601	54,028	17,968	17,025	24,221	34,091	39,423	31,940	34,590	34,102	34,890	36,967	36,220	36,827	35,480	34,879	15,839	15,933	16,067	18,960	21,159	21,764	22,100	22,803	12,347	12,204	11,911	13,153	13,593	14,121	15,190	9,261	9,412	9,756	9,585	7,701	7,358	7,484	7,776	7,045	6,660	6,345	6,573	6,454	6,727	6,804	6,058	6,058	4,788	4,330	4,052	4,052	3,845	3,833	4,107	4,500	4,300	4,500	4,900	5,300	5,400	5,900	6,500	3,400	3,600
Total Current Assets	28,770	28,173	27,565	29,690	35,310	42,358	47,245	35,288	35,288	46,082	52,399	59,242	69,469	77,943	51,536	59,494	36,874	40,565	48,262	40,190	46,825	32,093	35,531	44,246	48,828	61,188	63,804	74,750	78,509	79,784	83,977	85,762	84,626	87,904	88,441	94,005	94,707	19,894	21,697	22,342	31,918	38,942	49,260	14,188	13,149	20,004	29,397	33,841	25,897	28,102	30,266	28,136	32,666	31,672	32,112	30,599	29,949	11,049	11,303	11,523	14,429	16,540	17,259	17,815	18,646	8,030	7,799	7,530	9,059	9,588	10,243	11,281	5,380	5,894	6,286	6,217	4,241	3,957	4,106	4,270	3,739	3,730	3,348	3,525	3,331	3,501	3,537	2,666	2,666	2,190	1,914	1,971	1,971	2,081	2,053	2,237	2,500	2,300	2,400	2,600	2,900	3,000	3,500	4,300	900	1,000
Total Current Liabilities	16,637	21,408	17,452	15,070	17,691	19,338	18,535	20,966	20,966	21,756	34,038	11,232	12,793	12,708	11,495	13,357	12,374	12,394	14,835	15,730	13,205	12,685	11,232	8,439	9,143	7,620	7,667	10,391	10,146	7,313	9,179	8,009	8,091	8,474	7,032	10,340	9,804	17,280	15,315	14,096	17,850	18,072	16,789	28,474	26,987	23,049	17,419	13,836	13,692	9,625	6,373	5,726	6,420	4,870	5,931	5,630	5,537	7,016	6,341	5,423	7,098	6,748	5,109	4,837	4,637	5,902	5,621	4,890	4,453	3,745	2,707	2,665	4,682	4,831	5,270	5,199	3,460	3,095	3,231	3,488	2,946	2,995	2,743	2,875	2,627	3,002	2,909	2,569	2,569	2,157	1,388	1,171	1,171	1,099	792	727	900	600	600	700	700	600	600	500	1,700	1,500
Total Liab	30,882	31,088	28,509	27,930	32,529	38,050	38,971	46,039	46,039	47,605	45,481	43,271	43,578	43,161	42,373	45,052	23,997	24,385	27,484	28,584	25,281	25,414	24,529	24,590	25,866	25,016	25,630	29,852	30,197	27,097	29,513	28,893	25,502	26,487	25,538	29,339	29,297	29,332	29,795	30,321	35,767	37,500	36,789	28,474	26,987	23,049	17,419	13,837	13,695	9,628	6,377	5,732	6,429	4,881	5,940	5,643	5,556	7,042	6,371	5,452	7,139	6,806	5,210	4,987	4,842	6,143	5,893	5,206	4,779	4,160	3,150	3,271	5,416	5,398	5,914	5,950	4,278	3,953	4,145	4,502	3,873	3,626	3,427	3,588	3,408	3,791	3,744	3,462	3,462	2,222	1,469	1,191	1,191	1,099	792	727	900	600	600	700	700	500	600	500	1,700	1,500
Total Permanent Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Total Stockholder Equity	21,291	21,518	9,389	12,542	14,106	16,136	20,145	2,535	2,535	11,094	18,203	26,178	34,170	42,075	16,212	21,774	20,320	23,703	29,592	20,161	27,277	12,670	16,889	27,367	32,913	40,790	43,846	50,605	52,956	55,757	57,630	60,205	62,320	64,429	65,988	67,822	68,703	-5,460	-3,914	-3,527	596	6,101	17,239	-10,506	-9,962	1,172	16,672	25,585	18,245	24,963	27,725	29,158	30,538	31,339	30,887	29,837	29,323	8,797	9,562	10,615	11,821	14,352	16,554	17,113	17,961	6,204	6,311	6,706	8,374	9,434	10,971	11,918	3,845	4,014	3,842	3,635	3,422	3,405	3,340	3,274	3,172	3,034	2,918	2,985	3,046	2,936	3,061	2,597	2,597	2,566	2,861	2,861	2,861	2,746	3,041	3,380	3,600	3,700	3,900	4,200	4,600	4,900	5,300	6,000	1,700	2,100
Treasury Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-
Warrants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4,226	4,226	4,226	4,896	5,159	7,786	7,997	7,179	6,901	6,898	7,125	7,104	7,068	7,407	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-

Cash Flow

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31
Begin Period Cash Flow	10,102	13,280	48,682	11,795	22,714	8,407	17,181	31,198	65,800	11,881	4,712	5,715	12,263	23,038	5,597	11,097	2,663	299	166	107	0	83	211	1,093	1,900	100	0
Capital Expenditures	12,645	281	522	1,046	1,337	994	1,683	355	815	685	654	508	566	772	1,601	1,269	933	1,013	576	392	165	382	1,045	305	0	400	600
Cash And Cash Equivalents Changes	0	0	0	36,887	-10,965	14,307	-8,774	-14,018	-34,602	53,919	7,170	-1,004	-6,548	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	0	-1,511	-141	-3,443	-3,456	-3,793	-11,594	12,728	-9,207	17,122	4,994	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	-1,119	-3,178	-35,402	36,887	-10,919	14,307	-8,774	-14,018	-34,602	53,919	7,170	-1,004	-6,548	-10,775	17,441	-5,500	8,434	2,364	133	60	107	-83	-128	-882	-800	4,600	1,900
Change In Working Capital	-7,244	-2,608	-4,843	-2,958	-1,976	-3,432	-3,685	-3,793	-8,681	12,728	-11,070	14,800	4,994	-646	451	1,236	-791	416	-1,287	185	-317	-611	16	73	-300	-900	500
Change Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-4,642	-346	-1,742	32	2,777	-624	-962	-1,162	-575	106	-146	-209	284	-1,015	1,737	0	0	0	0	0	0	0	0	54	0	0	0
Change To Inventory	1,176	-2,101	-656	-1,306	317	-836	343	-6,096	-3,952	-1,121	-150	-146	433	151	73	-603	101	-608	-399	-302	126	-410	-481	-172	-200	100	0
Change To Liabilities	0	-3,512	-2,449	-751	-3,727	-2,124	-3,965	4,504	-3,381	16,101	0	9,470	1,705	271	0	2,228	63	1,125	0	458	0	558	418	214	0	0	0
Change To Netincome	0	915	1,099	1,624	6,227	14,499	7,749	10,381	8,951	10,978	6,091	5,065	4,492	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	3,351	4	-933	-1,343	152	899	-1,039	-774	-2,359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1,444	2,589	2,515	2,289	2,653	650	514	762	822	996	1,007	1,087	1,176	1,389	1,234	912	950	757	716	630	454	392	384	379	400	400	300
Dividends Paid	0	0	6	22,500	148	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	8,983	10,102	13,280	48,682	11,795	22,714	8,407	17,181	31,198	65,800	11,881	4,712	5,715	12,263	23,038	5,597	11,097	2,663	299	166	107	0	83	211	1,100	4,700	1,900
Exchange Rate Changes	0	0	0	0	0	0	1	-1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-22,057	-17,695	-34,056	-30,687	-28,592	-21,414	-22,797	-12,808	-17,056	3,573	-51,319	-31,255	-11,349	1,329	-3,028	-5,538	-4,331	-4,420	-1,070	634	61	-1,497	-1,965	-801	-900	-2,700	-1,800
Investments	-1,835	-2,396	311	4,258	38,266	33,895	16,185	-1,290	-20,331	-8,124	-12,002	12,025	-25	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	13,763	30,016	107	45,473	24,161	22,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	-13,193	-2,280	21,737	-1,145	-1,145	-1,145	-1,145	0	-21,100	18,888	-6	-18	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-8,439	-18,679	-32,674	-30,890	-34,128	-32,126	-25,921	-19,803	-14,420	-21,327	-48,783	-54,022	-21,445	-2,683	-5,501	-7,864	-3,719	-4,575	77	212	5	-981	-1,579	-1,017	-1,100	-1,900	-1,900
Other Cashflows From Financing Activities	-522	-191	6	41,125	-1,503	3	14,503	-1,644	-21,142	-8,809	18,890	11,518	-588	-12,922	-1,601	-204	-396	-2,320	908	-531	5	-323	1,417	-6	0	100	-600
Other Cashflows From Investing Activities	0	0	0	0	-42,428	-20,428	1	1	5	-8,124	7	2	-142	2	0	8	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	6,877	969	369	294	1,245	1,100	803	10,346	-2,913	1,758	452	7,302	-21,445	-2,683	1,950	1,448	162	-5	0	0	84	85	259	68	100	100	-100
Sale Purchase Of Stock	0	0	-6	-19	-279	22,003	-2,287	80	2,780	79,570	51,596	18,231	4,841	0	0	0	0	0	0	0	0	0	0	0	0	-1,300	0
Stock Based Compensation	932	315	943	475	4,952	4,388	7,175	10,346	8,888	10,095	7,712	7,302	4,378	4,021	403	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	11,342	16,632	-2,179	63,316	21,085	22,003	-2,164	80	2,780	58,470	70,484	18,225	4,823	47	20,469	28	12,766	6,784	1,254	-492	43	936	2,471	73	0	4,600	1,900
Total Cash From Operating Activities	-9,412	-17,414	-33,534	-29,641	-27,255	-20,420	-21,114	-12,453	-16,241	4,258	-50,665	-30,747	-10,783	2,101	-1,427	-4,268	-3,399	-3,407	-494	1,027	225	-1,115	-920	-496	-900	-2,300	-1,200
Total Cashflows From Investing Activities	0	-2,396	311	3,212	-4,750	12,723	14,503	-1,644	-21,142	-8,809	-12,650	11,518	-588	0	0	0	0	0	0	0	0	96	0	0	0	0	0

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31
Begin Period Cash Flow	7,759	8,959	10,894	10,102	12,980	30,780	9,914	23,390	23,390	32,378	35,675	48,682	56,614	26,697	37,400	11,795	14,421	21,417	20,920	22,714	4,292	1,748	3,278	8,407	3,888	8,328	11,900	17,181	19,293	23,822	30,008	31,198	33,173	37,146	63,333	65,800	3,017	2,859	661	11,881	21,213	40,952	5,774	4,712	1,174	6,470	13,639	5,715	8,422	9,318	7,952	12,263	23,657	24,200	24,634	23,038	2,768	3,335	3,353	5,597	7,482	9,736	10,641	11,097	242	0	3,031	2,663	4,035	4,748	5,695	299	451	1,276	866	166	62	306	369	107	213	28	50	0	59	12	12	-1,178	587	28	-525	446	446	480	836	1,093	1,000	1,100	1,300	1,900	0	0	3,600	100	0
Capital Expenditures	43	16	80	145	84	117	51	114	114	127	243	38	76	687	81	203	139	394	433	372	405	249	185	156	977	305	239	162	27	99	27	202	478	128	131	78	71	184	99	330	158	183	160	153	424	689	154	89	78	278	90	121	90	173	189	321	508	494	362	237	146	409	410	304	160	98	221	453	386	260	114	253	131	163	222	60	115	90	25	162	36	39	59	31	30	58	11	470	470	249	298	223	223	18	32	31	0	0	0	0	0	100	0	0	500
Cash And Cash Equivalents Changes	0	0	-1,934	795	0	0	0	0	0	0	-3,297	-13,007	-7,933	29,917	-10,741	25,644	-2,672	-6,996	498	-1,794	18,422	2,544	-1,530	-5,129	4,519	-4,440	-3,572	-5,281	-2,113	-4,528	-6,186	-1,191	-1,975	-3,973	-26,187	-2,468	62,784	158	2,198	-11,220	-9,331	-19,739	35,178	1,063	3,537	-5,296	-7,169	7,924	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Flows Other Operating	0	0	995	-2,572	0	0	0	0	0	0	2,734	-4,881	-980	1,594	-2,407	282	710	-470	-1,934	1,553	-5,009	2,852	397	-1,683	2,933	-1,027	-2,560	-2,802	2,861	-4,929	-2,604	879	63	-2,785	-7,218	-1,654	18,860	1,874	-2,787	-5,219	-1,492	1,163	-11,343	2,465	6,242	6,782	3,610	488	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change In Cash	1,224	-1,200	-1,935	792	-2,878	-17,800	20,866	-10,110	-10,110	-8,988	-3,297	-13,007	-7,932	29,917	-10,703	25,605	-2,627	-6,996	498	-1,794	18,422	2,544	-1,530	-5,129	4,519	-4,440	-3,572	-5,281	-2,113	-4,528	-6,186	-1,191	-1,975	-3,973	-26,187	-2,468	62,784	158	2,198	-11,220	-9,331	-19,739	35,178	1,063	3,537	-5,296	-7,169	7,924	-2,707	-896	1,366	-4,311	-11,394	-542	-435	1,596	20,270	-568	-18	-2,243	-1,885	-2,254	-905	-456	10,855	758	784	368	-1,372	-714	-946	5,396	-152	-825	409	700	104	-244	-63	262	-107	185	-23	50	-59	48	0	1,261	0	559	553	-235	-235	-34	-356	-258	100	-100	-200	-600	-100	-500	-100	3,500	-600
Change In Working Capital	-510	-4,140	463	-3,057	503	1,888	-1,783	-1,287	-1,287	-551	2,288	-5,293	-1,337	1,252	-2,764	-108	305	-924	-2,431	1,074	-4,999	1,784	466	-683	2,863	-1,097	-2,629	-2,821	2,861	-4,929	-2,604	879	63	-2,785	-4,305	-1,654	18,860	1,874	-2,787	-5,219	-1,919	929	-11,578	1,499	3,920	6,782	3,610	488	3,837	1,544	2,657	-3,043	1,106	-1,159	-1,639	1,046	-98	396	1,132	-978	619	-19	82	554	1,055	-435	-285	-1,126	-58	1,035	153	-715	-276	-1,273	-124	386	58	-100	-188	415	85	-147	-113	-142	16	336	-768	212	64	-34	-15	67	-182	187	-81	-99	-100	300	-200	-400	200	100	-200	-1,000	400
Change Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Account Receivables	-1,540	-3,950	610	238	1,108	723	-969	123	123	-679	1,240	-2,426	-42	-563	1,021	-384	920	266	1,323	268	602	-2,227	705	296	-813	-493	688	-345	1,822	-441	-1,367	-1,177	850	-1,958	727	-194	-282	29	-118	478	-356	354	-114	-30	-113	37	-141	8	36	239	191	-180	129	-38	-1,627	521	1,594	-341	124	360	0	0	335	542	0	0	0	0	0	87	359	0	0	0	0	0	0	0	0	36	0	0	116	0	0	0	0	0	0	0	0	0	54	0	106	238	0	0	0	0	0	0	0	0	0
Change To Inventory	-385	1,561	-219	219	-1,180	142	392	-102	-102	245	-375	-424	-353	349	-474	-828	24	227	-96	162	-4,505	2,359	1,251	59	2,735	141	-241	-2,291	-2,207	-751	-1,846	-1,292	-456	-1,100	-1,119	-1,276	-939	-197	126	-110	15	102	-51	-216	22	90	-352	94	-269	123	425	154	-402	329	-317	542	-414	139	3	346	5	-454	-40	-113	235	27	-164	3	-113	-2	-333	-160	11	317	270	-998	-215	-4	178	-261	4	215	-39	-55	592	91	-687	-258	-258	-153	-33	-59	-59	76	-24	-166	-100	0	0	0	0	0	0	0	0
Change To Liabilities	0	0	660	0	-1,397	-435	-1,627	-53	-1,643	-495	1,081	-1,392	-585	531	-356	-341	-739	-1,434	-1,020	-533	-3,115	3,152	-1,379	-782	-3,965	-247	-615	-346	1,863	-2,416	981	425	-3,381	0	0	0	16,101	0	0	0	0	0	0	1,267	9,470	2,726	1,046	0	1,705	0	0	0	271	0	53	381	0	0	0	0	2,228	994	212	435	63	0	24	443	1,125	629	0	0	0	0	0	499	458	268	370	570	0	0	0	16	558	637	485	414	418	534	69	59	214	156	0	0	0	0	0	0	0	0	0	0	0
Change To Netincome	0	0	308	194	523	473	103	-184	441	360	454	-156	752	541	-607	939	1,086	1,948	1,678	1,514	8,393	-1,772	5,368	2,499	1,165	1,910	2,411	2,263	2,552	2,609	2,540	2,680	2,792	1,163	3,165	1,831	4,325	2,016	2,349	2,288	1,199	2,107	1,429	1,356	2	2,029	1,534	1,500	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change To Operating Activities	0	0	-588	-588	1,972	1,458	421	-500	335	378	342	-1,051	-357	935	-2,955	1,445	101	17	-2,637	1,177	2,019	-1,499	888	-1,257	899	-498	-2,461	160	-1,039	-1,322	-11	-43	-774	0	0	0	-2,359	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	550	564	170	160	649	634	648	668	668	605	628	614	585	548	556	600	641	655	690	666	183	186	152	129	130	126	129	130	179	188	196	200	214	200	200	208	229	261	249	258	255	250	252	251	259	273	278	277	248	278	321	330	342	339	344	363	398	309	300	227	260	258	195	199	348	208	199	195	214	176	144	222	200	181	168	167	167	164	152	145	136	106	107	105	99	104	100	112	112	99	86	88	88	95	97	98	100	100	100	100	100	100	100	100	100
Dividends Paid	0	0	0	0	0	0	0	969	0	662	0	0	63,316	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
End Period Cash Flow	8,983	7,759	8,959	10,894	10,102	12,980	30,780	13,280	13,280	23,390	32,378	35,675	48,682	56,614	26,697	37,400	11,795	14,421	21,417	20,920	22,714	4,292	1,748	3,278	8,407	3,888	8,328	11,900	17,181	19,293	23,822	30,008	31,198	33,173	37,146	63,333	65,800	3,017	2,859	661	11,881	21,213	40,952	5,774	4,712	1,174	6,470	13,639	5,715	8,422	9,318	7,952	12,263	23,657	24,200	24,634	23,038	2,768	3,335	3,353	5,597	7,482	9,736	10,641	11,097	242	0	3,031	2,663	4,035	4,748	5,695	299	451	1,276	866	166	62	306	369	107	213	28	50	0	59	12	83	83	587	28	211	211	446	480	836	1,100	1,000	1,100	1,300	-100	-500	-100	3,600	-600
Exchange Rate Changes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-6	-5	-2	1	0	-1	1	-1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Free Cash Flow	-86	-3,769	-1,820	-4,021	-678	-1,219	-5,957	-9,140	-9,140	-7,202	-5,181	-12,533	-8,645	-5,604	-9,697	-6,741	-5,439	-6,569	-10,788	-5,795	-6,203	-5,021	-5,430	-4,760	-5,788	-4,354	-7,342	-5,313	511	-6,795	-5,256	-1,268	-3,179	-3,965	-6,520	-3,391	17,484	129	-3,345	-10,695	-8,301	-9,871	-21,686	-11,461	-6,747	-9,480	-6,638	-8,390	-3,612	-2,569	-486	-4,683	738	-591	-424	1,605	-132	-573	-124	-2,198	-1,960	-2,252	-900	-426	242	-758	-784	-3,031	-1,390	-670	-1,326	-1,034	-480	-1,099	-92	602	122	40	-5	478	292	30	-132	-129	63	209	-1,045	-544	-544	-587	-525	-157	-157	-30	-356	-258	0	-100	-200	-600	100	-400	-700	-1,400	-500
Investments	2,008	-10,291	16	5,302	3,218	-14,579	-51	9,162	654	-1,237	1,890	-474	713	2,561	-1,806	2,789	7,786	11,681	6,037	12,762	4,299	7,574	5,083	1,051	-23,937	6,771	33,351	31	-2,623	2,264	-931	-931	-20,331	-31	-20,300	0	-11,100	0	4,976	-2,000	-2,002	-10,001	0	0	10,038	3,987	-2,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Issuance Of Capital Stock	1,098	13,763	0	0	0	0	0	0	0	107	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Borrowings	0	0	-130	-503	-5,502	-2,002	-3,002	-2,687	-1,624	-656	-656	-656	-656	0	-1,159	21,553	-382	-763	-763	-763	-763	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-20,536	-564	0	0	0	-29	18,918	-1	-1	-1	-2	-3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-1,512	-1,872	-3,305	-1,750	-2,362	-4,189	-4,966	-8,941	-8,941	-7,581	-8,400	-7,752	-8,663	-7,351	-6,893	-7,984	-7,302	-7,855	-10,292	-8,678	-9,376	-4,970	-11,251	-6,530	-9,039	-5,057	-7,083	-4,742	-5,054	-4,563	-5,361	-4,824	-5,770	-2,415	-2,537	-3,699	-6,384	-3,968	-3,170	-7,806	-8,332	-13,208	-11,863	-15,380	-13,673	-17,876	-11,905	-10,567	-8,953	-5,042	-4,538	-2,912	-1,663	-743	117	-394	-550	-1,521	-1,715	-1,715	-3,033	-2,511	-1,110	-1,210	-1,163	-433	-477	-1,647	-1,155	-1,622	-1,509	-289	-274	156	85	109	11	65	55	80	100	85	-93	-87	-73	-183	-379	-478	-478	-460	-356	-120	-120	-307	-352	-238	-100	-300	-300	-400	-300	-500	-600	-500	-400
Other Cashflows From Financing Activities	-522	-43	-130	-631	-15,000	-2,002	14,809	1,070	-191	668	-6	-512	109,552	-2,330	-1,044	21,982	-105	-872	18,210	148	3	7,325	3,720	-522	9,322	116	5,819	-130	-2,650	2,164	-957	-202	-478	-160	-20,431	-73	-11,171	-184	4,877	-2,330	-2,159	-28	18,919	-147	10,461	3,298	-2,153	-88	905	1,543	-167	-203	-12,241	-173	-188	-321	-513	-494	-362	-232	-51	-48	-48	-57	-1,953	431	784	400	-77	-129	-181	-1,933	218	265	431	-5	-16	-209	-68	-238	-436	158	110	180	-222	-197	375	817	-1,104	467	553	77	77	-4	-32	-31	0	0	0	0	300	-200	-200	-200	-100
Other Cashflows From Investing Activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2,789	-7,476	-12,678	-13,211	-9,063	-1,944	-15,889	-1,178	-1,417	34,236	-6,973	-27,293	32	1	1	1	0	5	5	5	5	0	0	0	0	7	7	1	6	550	-550	1	0	0	0	0	0	2	0	0	0	0	0	0	3	8	9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	549	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non Cash Items	3,867	604	624	578	396	388	98	93	93	92	92	92	94	92	92	15	-1	1,072	177	-3	6,432	-2,387	5,732	1,303	1,141	1,643	2,112	2,278	2,552	2,572	2,543	2,679	1	60	-1,449	-1,464	1,047	259	226	226	25	1,905	1,663	2,317	59	-17,876	-11,905	-10,567	-8,953	-5,042	19	6	-1,663	-743	117	-394	-550	26	0	-5	339	429	344	335	162	0	0	0	-5	0	0	1	0	0	0	0	0	0	0	0	7	25	26	26	51	9	13	80	0	56	56	31	0	12	12	12	100	-200	200	100	100	0	-100	0	-100
Sale Purchase Of Stock	0	0	0	0	0	0	0	6	0	-6	0	-20	-1	1	-6,060	-99	-99	-85	18,210	-95	2	-2	0	0	7	116	0	0	0	3	77	77	1,205	23	633	919	76,935	593	567	1,475	971	162	37,945	12,519	248	198	1,468	16,317	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32	0	0	-32	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-200	-1,100	0
Stock Based Compensation	218	212	309	193	220	177	97	385	385	361	433	-236	751	250	-1,461	935	1,057	876	1,501	1,517	1,962	615	635	1,176	1,141	1,643	2,112	2,278	2,552	2,572	2,543	2,679	2,791	1,103	1,702	3,293	3,801	1,887	2,232	2,174	1,828	1,905	1,663	2,317	2,265	2,028	1,519	1,489	1,248	927	1,145	1,058	1,040	1,146	933	902	610	713	521	509	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Cash From Financing Activities	-742	12,845	-130	-631	-5,502	-2,002	26,823	-1,624	-1,624	-549	-6	-1	-1	32,960	799	29,557	2,502	321	18,210	52	22,005	-2	-2	7	7	116	-2,287	0	-80	3	77	77	1,205	23	633	919	56,399	29	567	1,475	971	133	56,863	12,518	247	197	1,467	16,314	902	1,538	1,929	453	19	48	-11	-9	20,407	6	106	-50	74	-11	-5	-30	10,855	758	784	368	18	-44	380	6,430	323	281	552	99	-10	-209	-57	-216	-405	158	110	180	-127	-148	1,107	1,261	1,261	559	553	77	77	-4	0	0	0	0	0	0	-200	0	-100	4,900	-100
Total Cash From Operating Activities	-43	-3,753	-1,740	-3,876	-594	-1,102	-5,906	-9,026	-9,026	-7,075	-4,938	-12,495	-8,569	-4,918	-9,616	-6,538	-5,301	-6,176	-10,355	-5,424	-5,798	-4,772	-5,245	-4,605	-4,812	-4,049	-7,103	-5,151	538	-6,696	-5,229	-1,066	-2,701	-3,837	-6,389	-3,314	17,556	314	-3,247	-10,365	-8,143	-9,688	-21,526	-11,308	-7,171	-8,791	-6,484	-8,302	-3,534	-2,291	-396	-4,562	828	-418	-235	1,926	376	-79	238	-1,961	-1,814	-1,843	-490	-122	402	-660	-563	-2,578	-1,003	-410	-1,212	-781	-349	-936	130	662	237	130	19	640	328	68	-73	-98	93	267	-1,034	-75	-75	-339	-228	66	66	-12	-324	-227	0	-100	-200	-600	100	-300	-700	-1,400	0
Total Cashflows From Investing Activities	0	0	-64	5,302	3,218	-14,696	-51	9,133	540	-1,364	1,647	-512	637	1,875	-1,886	2,586	172	-1,141	-7,358	3,577	2,200	7,325	3,720	-522	9,322	-507	5,819	-130	-2,650	2,164	-957	-202	-478	-160	-20,431	-73	-11,171	-184	4,877	-2,330	-2,159	-10,184	-159	-147	10,461	3,298	-2,153	-88	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	96	122	192	265	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Income Statement

Currency in USD. All numbers in thousands.

	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31
Cost Of Revenue	74,908	68,733	64,351	59,472	58,464	64,973	53,598	46,532	46,413	45,643	45,720	43,149	43,323	49,694	46,842	48,649	40,015	25,837	24,690	15,139	12,414	10,042	8,103	6,098	5,400	5,000	3,500
Depreciation And Amortization	1,444	33	2,537	1,690	-30	650	514	762	822	996	1,007	1,087	1,176	1,389	1,234	912	950	757	716	630	454	392	384	379	400	400	300
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	-6,670	-16,780	-30,336	-28,420	-34,095	-31,837	-25,924	-19,398	-15,102	-17,173	-46,961	-54,021	-21,441	-2,869	-5,481	-8,085	-3,608	-4,638	0	409	188	-862	-1,392	-1,045	-1,100	-2,000	-1,900
Ebitda	-5,226	-16,747	-27,799	-26,730	-34,125	-31,187	-25,409	-18,636	-14,280	-16,177	-45,954	-52,933	-20,265	-1,480	-4,248	-7,173	-2,659	-3,881	716	1,039	642	-470	-1,007	-666	-700	-1,600	-1,600
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	8,704	4,077	-2,420	2,725	2,839	-1,585	3,702	6,753	8,938	8,545	6,659	6,693	5,643	9,861	7,887	3,017	3,030	2,802	3,005	2,805	2,556	1,454	912	1,359	1,300	300	-200
Income Before Tax	-8,439	-18,679	-32,674	-30,890	-34,128	-32,126	-25,921	-19,398	-14,420	-21,327	-48,783	-54,022	-21,443	-2,683	-5,501	-7,864	-3,719	-4,575	77	212	5	-981	-1,579	0	0	0	0
Income Tax Expense	0	1,899	2,360	1,042	-3,050	313	-2	405	0	386	98	242	2	-205	0	0	0	0	61	0	0	116	139	-28	0	-100	0
Interest Expense	2,301	1,936	2,360	1,879	0	0	25,922,918	20,208,729	15,102,326	4,154	1,822	1	2	10	20	8,085	111	0	198	198	183	116	90	0	0	100	0
Interest Income	211	33	22	238	367	535	1	810	682	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-8,439	-20,578	-35,034	-31,932	-31,078	-32,126	-25,921	-19,803	-14,420	-21,327	-48,783	-54,022	-21,445	-2,683	-5,501	-7,864	-3,719	-4,575	77	212	5	-981	-1,579	-1,017	-1,100	-1,900	-1,900
Net Income Applicable To Common Shares	0	-18,679	-32,674	-30,890	-34,128	-32,126	-25,921	-19,803	-14,420	-21,327	-48,783	-54,022	-21,445	0	0	0	0	0	77	212	5	0	0	0	0	0	0
Net Income From Continuing Ops	-9,289	-18,679	-32,674	-30,890	-34,128	-32,126	-25,921	-19,803	-14,420	-21,327	-48,783	-54,022	-21,445	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	-1,420	-1,903	-2,338	-1,641	367	535	1	810	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	0	0	-2,470	397	313	2	810	682	386	98	242	244	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	0	430	2,130	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-6,670	-16,780	-30,336	-28,420	-34,095	-32,439	-25,923	-20,209	-15,102	-17,559	-47,059	-54,262	-21,685	-2,869	-5,481	-8,085	-3,608	-4,638	137	409	188	-862	-1,440	-1,045	-1,100	-2,000	-1,900
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	90,282	89,590	92,267	90,617	95,398	94,798	83,223	73,493	70,453	71,748	99,439	104,104	70,651	62,424	60,211	59,751	46,654	33,277	27,558	17,536	14,782	12,358	10,456	8,502	7,800	7,300	5,200
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	3,061	2,589	2,515	2,289	2,653	650	514	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Research Development	1,107	3,119	6,835	7,092	6,886	6,742	6,321	5,840	4,961	7,784	39,382	48,272	17,805	3,422	6,454	3,830	3,264	4,778	350	200	250	120	0	0	0	0	0
Selling And Marketing Expenses	2,125	2,094	5,733	7,871	9,050	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	12,142	15,644	15,348	16,182	20,998	23,082	23,303	21,121	19,079	18,321	14,336	12,684	9,522	9,308	6,914	7,272	3,374	7,439	2,868	2,396	2,368	2,319	2,353	2,024	0	0	0
Tax Provision	0	0	0	0	0	0	0	405	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	15,374	20,857	27,916	31,145	36,934	29,825	29,625	26,961	24,040	26,104	53,718	60,956	27,328	12,730	13,369	11,102	6,638	7,439	2,868	2,396	2,368	2,316	2,353	2,404	2,400	2,300	1,700
Total Other Income Expense Net	-1,769	-1,899	-2,338	-2,470	-33	-1,252	1	810	682	-3,768	-1,724	241	242	-19	-20	221	-111	63	137	-198	-183	-3	-49	0	0	0	0
Total Revenue	83,612	72,810	61,931	62,197	61,303	63,389	57,300	53,284	55,351	54,188	52,380	49,842	48,966	59,555	54,730	51,666	43,045	28,639	27,695	17,945	14,970	11,496	9,016	7,457	6,700	5,300	3,300

	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31	2003-12-31	2003-09-30	2003-06-30	2003-03-31	2002-12-31	2002-09-30	2002-06-30	2002-03-31	2001-12-31	2001-09-30	2001-06-30	2001-03-31	2000-12-31	2000-09-30	2000-06-30	2000-03-31	1999-12-31	1999-09-30	1999-06-30	1999-03-31	1998-12-31	1998-09-30	1998-06-30	1998-03-31	1997-12-31
Cost Of Revenue	19,223	21,569	17,047	17,069	16,973	17,914	16,937	17,563	17,563	16,317	15,399	15,072	14,779	14,934	15,015	14,744	14,379	15,424	14,113	14,549	15,670	14,704	18,930	14,919	16,063	13,556	11,745	12,235	11,402	11,235	11,963	11,932	12,076	11,875	10,890	11,572	11,871	11,474	11,014	11,284	11,905	11,461	11,299	11,055	11,298	11,043	10,406	10,402	10,353	10,600	10,731	11,639	11,947	12,345	12,735	12,666	12,334	11,751	11,153	11,604	13,249	12,755	11,091	11,555	11,073	9,954	9,431	9,557	8,269	6,786	5,404	5,379	5,891	6,868	6,981	4,950	4,072	3,753	3,701	3,613	3,347	3,225	2,881	2,962	3,043	2,467	2,298	2,129	2,129	2,070	1,914	1,682	1,682	1,679	1,398	1,339	1,500	1,300	1,300	1,300	1,300	1,400	1,100	1,000	1,000
Depreciation And Amortization	550	564	170	224	45	634	648	668	0	605	628	614	585	548	556	600	641	655	690	666	183	186	152	129	130	126	129	130	179	188	196	200	214	200	200	208	229	261	249	258	255	250	252	251	259	273	278	277	248	278	321	330	342	339	344	363	398	309	300	227	260	258	195	199	348	208	199	195	214	176	144	222	200	181	168	167	167	164	152	145	136	106	107	105	99	104	100	112	112	99	86	88	88	95	97	98	100	100	100	100	100	100	100	100	100
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Ebit	-547	-2,301	-2,910	-1,427	-1,966	-3,708	-4,482	-8,353	-8,359	-6,972	-7,816	-7,171	-8,073	-6,688	-6,374	-7,884	-8,050	-7,948	-10,635	-8,824	-9,608	-5,184	-11,267	-6,699	-9,351	-5,025	-6,718	-4,958	-5,233	-4,752	-5,588	-4,420	-6,277	-2,415	-2,537	-3,699	-4,834	-3,076	-2,561	-6,951	-7,715	-12,351	-12,023	-15,380	-13,673	-18,149	-11,905	-10,567	-8,952	-5,039	-4,859	-2,912	-1,625	-759	109	-399	-550	-1,517	-1,707	-1,706	-3,071	-2,529	-1,130	-1,355	-1,154	-381	-442	-1,631	-1,186	-1,621	-1,540	-291	-207	201	122	-116	71	114	99	125	146	126	-36	-47	-50	-142	-354	-388	-388	-436	-337	-126	-126	-305	-362	-251	0	-300	-400	-300	-300	-500	-400	-500	-400
Ebitda	3	-1,737	-2,740	-1,203	-1,921	-3,074	-3,834	-7,685	-7,685	-6,367	-7,188	-6,557	-7,488	-6,140	-5,818	-7,284	-7,409	-7,293	-9,945	-8,158	-9,425	-4,999	-11,115	-6,570	-9,222	-4,899	-6,590	-4,828	-5,054	-4,565	-5,392	-4,220	-6,063	-2,215	-2,336	-3,491	-4,605	-2,815	-2,312	-6,693	-7,460	-12,101	-11,771	-15,129	-13,415	-17,876	-11,627	-10,289	-8,704	-4,762	-4,538	-2,582	-1,283	-420	453	-35	-153	-1,209	-1,407	-1,479	-2,811	-2,271	-935	-1,156	-806	-173	-244	-1,437	-971	-1,445	-1,396	-69	-7	382	290	51	238	279	252	270	281	232	71	58	49	-38	-254	-276	-276	-337	-251	-38	-38	-210	-265	-153	100	-200	-300	-200	-200	-400	-300	-400	-300
Effect Of Accounting Charges	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Extraordinary Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	2,870	2,202	1,033	2,599	2,340	777	1,745	-2,231	-2,231	-329	-262	401	385	346	881	1,113	1,112	-16	733	1,010	1,184	1,969	-4,017	30	-1,225	1,071	1,498	2,357	1,988	1,580	1,490	1,695	2,056	2,503	2,066	2,312	2,577	2,270	2,019	1,680	2,060	1,633	1,685	1,281	1,702	1,646	1,719	1,626	1,544	1,376	1,071	1,652	2,375	2,400	2,772	2,314	2,428	2,407	1,860	1,193	289	779	1,092	857	876	1,120	1,117	-83	960	593	465	783	565	960	810	669	708	721	682	695	796	714	572	473	562	416	264	205	205	188	259	466	466	305	292	296	500	300	200	300	300	100	100	0	0
Income Before Tax	-1,512	-1,872	-3,305	-1,750	-2,360	-4,190	-4,967	-8,941	-8,941	-7,581	-8,400	-7,752	-8,663	-7,350	-6,893	-7,984	-7,302	-7,855	-10,292	-8,678	-9,376	-4,970	-12,231	-6,530	-9,039	-5,057	-7,083	-4,742	-5,054	-4,563	-5,361	-4,420	-5,770	-2,415	-2,537	-3,699	-6,384	-3,968	-3,170	-7,806	-8,332	-13,208	-11,863	-15,380	-13,673	-17,876	-11,905	-10,567	-8,952	-5,040	-4,538	-2,912	-2,683	-743	117	0	-5,501	0	0	0	-7,864	0	0	0	-3,719	0	0	0	3,420	0	0	0	-79	156	86	159	12	65	55	80	100	85	0	0	0	0	0	-316	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense	0	-564	49	710	394	482	485	2,360	0	0	583	11	8,653	666	-317	102	-741	-87	-769	-131	-232	-186	-66	0	-311	0	-365	0	404,122	-1	1	405	-214	157	118	114	187	55	-179	74	-186	14	-247	11	11	-231	77	111	0	2	-243	86	-1,020	0	0	-5	-4,951	4	7	9	-4,831	-18	-20	-145	-2,556	52	34	15	-63	0	-31	-2	67	45	37	-87	60	49	45	44	46	41	57	39	23	41	25	90	0	24	18	-6	0	2	-11	-13	100	0	0	100	0	0	100	0	0
Interest Expense	1,108	411	395	387	439	482	485	588	588	609	583	581	590	666	521	102	0	0	0	0	0	0	0	180	180	32	365	0	20,208,729	0	0	0	0	0	0	1,550	1,550	892	858	854	872	858	92	0	0	0	0	0	0	0	1	1	2,869	16	8	5	1	4	7	9	8,085	18	20	145	9	52	34	15	0	0	0	0	67	45	37	50	60	49	45	44	46	41	56	40	20	41	25	41	41	24	18	7	0	2	0	0	0	0	0	0	0	0	0	0	0
Interest Income	42	56	49	64	45	0	0	0	5	0	7	11	1	2	67	171	94	81	74	131	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income	-1,512	-1,872	-3,305	-2,460	-2,754	-4,672	-5,452	-8,941	-8,941	-7,581	-8,400	-7,752	-8,663	-7,350	-6,893	-7,984	-7,302	-7,855	-10,292	-8,678	-9,376	-4,970	-12,231	-6,530	-9,039	-5,057	-7,083	-4,742	-5,054	-4,563	-5,361	-4,824	-5,770	-2,415	-2,537	-3,699	-6,384	-3,968	-3,170	-7,806	-8,332	-13,208	-11,863	-15,380	-13,673	-17,876	-11,905	-10,567	-8,953	-5,042	-4,538	-2,912	-1,663	-743	117	-394	-550	-1,521	-1,715	-1,715	-3,033	-2,511	-1,110	-1,210	-1,163	-433	-477	-1,647	-1,155	-1,622	-1,509	-289	-274	156	85	109	11	65	55	80	100	85	-93	-87	-73	-183	-379	-478	-478	-460	-356	-120	-120	-307	-352	-238	-100	-300	-400	-400	-300	-500	-500	-500	-400
Net Income Applicable To Common Shares	0	0	-3,305	-1,750	-2,362	-4,190	-4,967	-7,162	-8,941	-7,581	-8,400	-7,752	-8,663	-7,350	-6,893	-7,984	-7,302	-7,855	-10,292	-8,678	-9,376	-4,970	-12,231	-5,550	-9,039	-5,057	-7,083	-4,742	-5,054	-4,563	-5,361	-4,824	-5,770	-2,415	-2,537	-3,699	-6,384	-3,968	-3,170	-7,806	-8,332	-13,208	-11,863	-15,380	-13,673	-17,876	-11,905	-10,567	0	-5,042	-4,538	0	0	-117	117	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-79	156	86	109	12	65	55	80	100	85	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income From Continuing Ops	-1,512	-1,872	-3,305	-1,750	-2,362	-4,190	-4,967	-7,162	-8,941	-7,581	-8,400	-7,752	-8,663	-7,350	-6,893	-7,984	-7,302	-7,855	-10,292	-8,678	-9,376	-4,970	-12,231	-5,550	-9,039	-5,057	-7,083	-4,742	-5,054	-4,563	-5,361	-4,824	-5,770	-2,415	-2,537	-3,699	-6,384	-3,968	-3,170	-7,806	-8,332	-13,208	-11,863	-15,380	-13,673	-17,876	-11,905	-10,567	0	-5,042	-4,538	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Interest Income	-1,066	-355	-346	-323	-396	-482	-485	-540	-583	-609	-576	-570	-591	-664	-454	69	94	81	74	118	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Operating Income Net Other	0	0	-346	-323	0	0	0	0	0	0	-577	-570	-592	-660	-1,289	71	100	87	79	131	49	29	66	169	182	-32	-365	216	208	189	227	187	293	157	118	114	187	55	70	74	69	14	5	11	11	42	77	111	0	77	78	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non Recurring	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	430	0	1,100	0	1,030	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-547	-1,737	-2,959	-1,427	-1,966	-3,708	-4,482	-8,359	-8,359	-6,972	-7,823	-7,182	-8,072	-6,690	-5,603	-8,055	-7,403	-7,942	-10,371	-8,810	-9,425	-4,999	-12,297	-6,699	-9,221	-5,025	-6,718	-4,958	-5,262	-4,752	-5,588	-4,606	-6,063	-2,571	-2,655	-3,813	-5,021	-3,131	-2,382	-7,025	-7,529	-12,364	-11,776	-15,390	-13,684	-17,918	-11,982	-10,678	-8,956	-5,116	-4,615	-2,998	-1,820	-759	109	-399	-550	-1,517	-1,707	-1,706	-3,071	-2,529	-1,130	-1,355	-1,154	-381	-442	-1,631	-1,186	-1,621	-1,540	-291	-207	201	122	22	71	114	99	125	146	126	-36	-47	-50	-142	-354	-388	-388	-436	-337	-126	-126	-305	-362	-251	-100	-300	-400	-300	-300	-500	-400	-500	-400
Other Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	22,640	25,508	21,039	21,095	21,279	22,399	23,164	23,691	0	22,960	22,960	22,655	23,236	21,970	21,499	23,911	22,893	23,349	24,787	24,369	26,279	21,671	26,180	21,647	24,059	19,652	19,961	19,550	18,652	17,567	19,041	18,233	20,196	16,950	15,610	17,697	19,468	16,875	15,415	19,989	21,494	25,459	24,760	27,727	26,684	30,607	24,107	22,706	20,852	17,093	16,418	16,288	16,143	15,505	15,398	15,379	15,312	15,676	14,720	14,503	16,609	16,063	13,312	13,767	13,103	11,455	10,991	11,106	10,414	9,000	7,409	6,453	6,664	7,627	7,669	5,598	4,709	4,359	4,284	4,183	3,997	3,813	3,490	3,482	3,655	3,025	2,917	2,722	2,722	2,695	2,511	2,274	2,274	2,290	2,053	1,885	2,100	1,900	1,900	1,900	1,900	2,000	1,600	1,500	1,400
Preferred Stock And Other Adjustments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reconciled Depreciation	550	564	170	160	649	634	648	658	668	605	628	614	585	548	556	600	641	655	690	666	183	186	152	129	130	126	129	130	179	188	196	200	214	200	200	208	229	261	249	258	255	250	252	251	259	273	278	277	248	278	321	330	342	339	344	363	398	309	300	227	260	258	195	199	348	208	199	195	214	176	144	222	200	181	168	167	167	164	152	145	136	106	107	105	99	104	100	112	112	99	86	88	88	95	97	98	100	100	100	100	100	100	100	100	100
Research Development	168	494	167	278	156	469	926	1,390	1,390	1,221	2,416	1,809	1,909	1,745	1,616	1,821	1,956	1,475	2,958	497	2,709	808	1,559	1,666	2,126	1,305	1,675	1,215	1,201	1,262	2,063	1,314	2,030	1,247	885	800	1,680	1,302	187	4,615	5,794	10,611	10,223	12,755	11,751	16,238	10,876	9,406	7,868	4,221	3,314	2,403	1,735	728	441	517	1,142	1,978	1,997	1,338	1,272	993	782	783	944	735	762	823	1,396	1,622	1,311	449	190	74	37	49	200	0	0	0	250	0	0	0	120	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling And Marketing Expenses	541	556	530	498	352	762	526	873	0	1,541	1,468	1,851	2,133	1,669	1,997	2,073	1,901	1,827	2,219	3,102	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling General Administrative	2,708	2,889	3,295	3,250	3,798	3,254	4,775	3,865	4,738	3,881	3,677	3,923	4,415	3,622	2,871	5,273	4,657	4,624	5,497	6,220	7,900	6,159	5,691	5,062	5,870	4,792	6,541	6,101	6,050	5,070	5,014	4,987	6,090	3,828	3,836	5,326	5,917	4,099	4,214	4,090	3,795	3,386	3,238	3,917	3,635	3,325	2,824	2,899	2,632	2,271	2,373	2,247	2,460	2,431	2,221	2,195	1,836	1,947	1,571	1,561	2,088	2,314	1,440	1,430	1,086	765	798	726	2,145	2,214	2,005	1,075	773	759	688	648	636	607	583	570	651	588	609	520	615	558	618	528	594	624	597	538	503	515	558	448	0	0	0	0	0	0	0	0	0
Tax Provision	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Operating Expenses	3,417	3,939	3,992	4,026	4,306	4,485	6,227	6,128	23,691	6,643	7,561	7,583	8,457	7,036	6,484	9,168	8,514	7,926	10,674	9,820	10,609	6,967	7,250	6,728	7,996	6,096	8,217	7,316	7,250	6,332	7,078	6,301	8,119	5,075	4,721	6,125	7,597	5,401	4,401	8,705	9,589	13,998	13,461	16,671	15,387	19,564	13,701	12,304	10,500	6,492	5,686	4,649	4,195	3,159	2,663	2,712	2,978	3,924	3,567	2,899	3,360	3,307	2,221	2,212	2,030	1,501	1,559	1,549	2,145	2,215	2,005	1,075	773	759	688	648	637	606	583	570	650	588	609	520	612	558	618	593	593	624	597	592	592	610	655	547	600	600	600	600	600	600	500	500	400
Total Other Income Expense Net	-965	-135	-346	-323	-394	-482	-485	-2,360	0	-609	-1	-570	8,063	4	-835	2	6	6	-426	14	0	29	-1,030	169	1	-32	-729	216	208	189	227	187	293	157	118	114	-1,363	-837	-788	-780	-803	-844	-88	11	11	42	77	111	3	77	77	85	-3,732	16	8	0	-10,432	0	0	0	-12,878	0	0	0	-6,174	0	0	0	-32	0	0	0	0	0	0	137	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Revenue	22,093	23,771	18,080	19,668	19,313	18,691	18,682	15,332	15,332	15,988	15,137	15,473	15,164	15,280	15,896	15,857	15,490	15,407	14,846	15,559	16,854	16,672	14,913	14,949	14,838	14,627	13,243	14,592	13,390	12,815	13,453	13,627	14,133	14,379	12,956	13,884	14,448	13,744	13,033	12,964	13,965	13,094	12,984	12,336	13,000	12,689	12,125	12,028	11,897	11,976	11,802	13,291	14,323	14,745	15,507	14,980	14,761	14,158	13,013	12,797	13,538	13,534	12,182	12,412	11,949	11,074	10,548	9,474	9,229	7,379	5,869	6,162	6,456	7,828	7,791	5,620	4,780	4,474	4,383	4,308	4,143	3,939	3,454	3,435	3,605	2,883	2,563	2,334	2,334	2,259	2,173	2,148	2,148	1,984	1,690	1,634	2,000	1,600	1,500	1,600	1,600	1,500	1,200	1,000	1,000

Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue	83,612
Cost of Revenue	-74,908
Gross Profit	8,704	8,704

Operating Income (+$)
Gross Profit	8,704
Operating Expense	-15,374
Operating Income	-6,670	-6,670

Operating Expense (+$)
Research Development	1,107
Selling General Administrative	12,142
Selling And Marketing Expenses	2,125
Operating Expense	15,374	15,374

Net Interest Income (+$)
Interest Income	211
Interest Expense	-2,301
Other Finance Cost	-670
Net Interest Income	-1,420

Pretax Income (+$)
Operating Income	-6,670
Net Interest Income	-1,420
Other Non-Operating Income Expenses	0
Income Before Tax (EBT)	-8,439	-4,901 EBIT - interestExpense = -8,971 -8,439 -6,138
Interest Expense	2,301
Earnings Before Interest and Taxes (EBIT)	-6,670	-6,138
Earnings Before Interest and Taxes (EBITDA)	-5,226

After tax Income (+$)
Income Before Tax	-8,439
Tax Provision	-0
Net Income From Continuing Ops	-9,289	-8,439
Net Income	-8,439
Net Income Applicable To Common Shares	0

Non-recurring Events
Discontinued Operations	0
Extraordinary Items	0
Effect of Accounting Charges	0
Other Items	0
Non Recurring	0
Other Operating Expenses	90,282
Total Other Income/Expenses Net	-1,769	1,420

Technical Analysis of Rockwell Medical Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Rockwell Medical Inc. The general trend of Rockwell Medical Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Rockwell Medical Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator State	Bullish trend		Bearish trend
Overbought to neutral	Bullish pullback	=	Bearish reversal
Upper to lower neutral	Bullish correction	=	Bearish continuation
Nuetral to oversold	Oversold	=	Oversold
Oversold to neutral	Bullish reversal	=	Bearish correction
Lower to upper neutral	Bullish continuation	=	Bearish pullback
Nuetral to overbought	Overbought	=	Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.

Score

Let's take a look at the Support & Resistance of Rockwell Medical Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.76 < 1.81 < 2.07.

The bearish price targets are: 1.45 > 1.45 > 1.35.

Tweet this

Rockwell Medical Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

Moving averages are lagging trend indicators.
There are many types of moving averages.
Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Rockwell Medical Inc. The current mas is .

Directionalities and relatives.

Moving Average	Amount of candles	Trend	Price +/-	vs. MA 50	vs. MA 100	vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Shows the moving average of the selected period.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

There are various kinds of moving averages:

Simple moving average (SMA);
Exponential moving average (EMA);
Smoothed moving average (SMMA);
Linear weighted moving average (LWMA).

The moving average looks at a certain period of time and it calculates the price average. The various types of averages are using various formulas. Don’t worry, you don’t have to memorize any formula. All moving averages are calculated automatically by basically every charting software you use. But it’s good to know how moving averages are actually calculated.

Simple moving average

SMA is calculated by summing up the price closures of the selected period. The price is then divided by the selected period. For example, when using the 21 day moving average you sum up all the closing prices for each day and divide that by 21. The result is a line on the chart representing the average. Because it’s an average in the selected timeframe, the trend is always lagging. An moving average looks like this on the chart:

Source: Tradingview.com

In this case, the blue line represents a 21 day moving average. Because the average is based on results from the past, the indicator will always lag behind. For example, when price would suddenly go up, the moving average won't immediately follow.

All other moving averages discussed below look the same on the chart. The only difference is that the line will move in different directions based on the maths behind the used indicators and the amount of days used to determine the average.

Exponential moving average

The EMA gives more weight to the latest closing prices by giving them more value in the equation. EMA is calculated by adding a certain percentage to the latest closing prices:

EMA = (CLOSE (i) * P) + (EMA (i - 1) * (1 - P))

Where:

CLOSE (i) = current period close price.
EMA (i - 1) = value of the Moving Average of a preceding period.
P = the percentage of using the price value.

Smoothed moving average

A smoothed moving average is an exponential moving average with a long lookback period. Older prices are reduced in weight but are never left out in the calculation. Unlike SMA and EMA where prices are removed when they are beyond the selected period. SMMA is a combination of the SMA and EMA. The main advantage is that it smooths out fluctuations in price.

Linear weighted moving average

The LWMA gives the latest price the highest weight and then lineary scales down with each price before that. The result is that the LWMA reacts quicker to changes in price than the SMA or EMA. The formula:

LWMA = ((Pn∗W1)+(Pn−1∗W2)+(Pn−2∗W3)...) / ∑W

Where:

P = Price for the period.
n = The most recent period, n-1 is the prior period, and n-2 is two periods prior.
W = The assigned weight to each period, with the highest weight going first and then descending linearly based on the number of periods being used.

Moving averages are widely used by many traders. Which moving average you need depends on your trading strategy. Common practise is using a combination of multiple periods. For example, the EMA21, EMA50, EMA100 and EMA200. How does that look on a chart:

Source: Tradingview.com

The lowest (purple) line on the chart represents the EMA200 then following up the EMA100, EMA50 and EMA21.

You can use moving averages to determine a trend. The 200 moving average is mostly used as a baseline for determining the current trend:

When the 200 moving average is moving up it is considered a bullish trend.
When the 200 moving average is down it is considered a bearish trend.
When moving averages are flatlined, there is no clear trend so you should look for market structure, consolidation or trend reversals. Depending on how you want to trade.

This is not set in stone. Most trading strategies use multiple moving averages each with different settings. While one strategy might use the EMA20, the other uses the SMA21. There can be hundreds of different variations. Moving averages can also be used as support and resistance. More often than not, prices will bounce on moving averages.

Rockwell Medical Inc Daily Moving Averages Chart

2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

MACD is a lagging momentum indicator.
Uses two moving averages.
Can show buy or sell signals based on momentum.
Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Rockwell Medical Inc.

Rockwell Medical Inc Daily Moving Average Convergence/Divergence (MACD) Chart

2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.

Score

Let's take a look at the Directional Movement Index (DMI) of Rockwell Medical Inc. The current adx is .

Rockwell Medical Inc Daily Directional Movement Index (DMI) Chart

2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

Parabolic SAR (stop and reverse) is a lagging trend indicator.
Shows the current trend.
Shows potential entry signals.
Shows potential exit signals.
Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Rockwell Medical Inc.

Rockwell Medical Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

Leading momentum indicator, meaning the signals are instant.
Ranges between 0 and 100.
Above 70 is considered overbought.
Below 30 is considered oversold.
Above or below 50 can also be used to determine price trend or support and resistance.
RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Rockwell Medical Inc.

Measures the speed and change of price movements.

There are four types of indicators:

Trend indicators
Momentum indicators
Volatility indicators
Volume indicators

The RSI measures the magnitude of recent price changes to determine if the asset is overbought or oversold.

Overbought (RSI above 70) means that the trading price is above its intrinsic value. This might indicate a sell or short signal.
Oversold (RSI below 30) means that the trading price is below its intrinsic value. This might indicate a buy or long signal.
RSI levels above or below 50 can also be used to determine a trend.
RSI divergence looks at a deviation between RSI and price movement.
Can be used in many different ways.

Original usage

Keep in mind that almost every indicator can be used in different ways. Even beyond the orginal settings. The relative strength index was developed by J. Welles Wilder. Wilder recommended a smoothing period of 14 days. That means a 14 day moving average (read more about this setting below). Another quote from the wikipedia page:

Wilders also considers the RSI 50 line as both support and resistance. I recommend to always read the original settings first before using an indicator. Many traders and websites are using their own version of the indicator which might be confusing.

How you can use RSI (Divergence)

First and foremost, there is no real right or wrong usage of the RSI indicator. You can use it in any way you want. Wilder recommends using a 14 day average but you can make it 50 or 100 if you like. Just keep in mind that using an indicator is just part of a larger trading plan. In other words, it’s not recommended to do any trading or investing based on a single indicator like the RSI.

The RSI is measured on a scale between 0 and 100. From 30 till 0 is considered oversold. and from 70 -100 is overbought. The RSI is a leading indicator, meaning the signals are instant.

I like to use the RSI as a trend\momentum indicator and not as an overbought or oversold indicator. I use the middle (50) as the baseline. When prices go above RSI 50 the trend is bullish and can indicate long positions. When below 50 it is considered bearish and can indicate short positions. Other traders use the 70 and 30 levels as overbought/oversold depending on the used strategy. The RSI indicator looks like this:

Source: Tradingview.com

The general concensus is that an RSI above 70 indicates that the security is overbought. In other words, the price this security is trading for is to high and should come down. So if RSI hits 70 or above this might indicate a sell signal or taking a short position (expecting the price will go down). Although RSI above 70 indicates the security is trading above it's fair value, that does not mean the price will go down.

Use tradingview to add indicators

I highly recommend using tradingview to add indicators to a chart. It has all the indicators you can think off and can add them for free (up to three indicators) to any chart you want. You can see that the levels 30 and 70 are marked with a dotted line. If you want you can remove these lines or give it another colour using Tradingview. You can also adjust the moving average used. You can also find RSI indicators made by the community that include other settings like RSI divergences.

Tradingview

Use Tradingview to (back)test your strategies and add hundreds of indicators created by the community.

View tool on Tradingview.com

RSI divergence

RSI is not only used to determine momentum but can also spot reversals or continuations of the trend. A reversal means that the trend is going in the opposite direction. From bullish to bearish or from bearish to bullish. These reversals can be spotted by looking at the price and the direction of the RSI. When the price is going up but the RSI is going down that means there is a divergence. This is also the case when RSI goes up but price is going down.

There are four types of divergences:

Regular bullish divergence
Regular bearish divergence
Hidden bullish divergence
Hidden bearish divergence

Regular bullish divergence

With a regular bullish divergence, the price is making lower highs but the oscillator (in this case the RSI) is making higher lows. A regular bullish divergence might indicate the end of the current trend. You’ll see regular bullish divergences mostly at the end of a downtrend. But that does not mean that every regular bullish divergence is a trend reversal.

Price is making lower highs
RSI is making higher lows
Indicating bullish reversal (price might go up)

Source: Tradingview.com

Regular bearish divergence

With a regular bearish divergence the price is making higher highs but the oscillator (in this case the RSI) is making lower highs. This might indicate the end of an uptrend.

Price is making higher highs
RSI is making lower highs
Indicating bearish reversal

Source: Tradingview.com

Hidden bullish divergence

With a hidden bullish divergence, the price is making a higher low while the RSI is making a lower low. This might indicate bullish trend continuation.

Price is making higher lows
RSI is making lower lows
Indicating bullish continuation

Source: Tradingview.com

As you have noticed, you can have multiple divergences in a row.

Hidden bearish divergence

With a hidden bearish divergence, price is making lower highs but RSI is making higher highs. This might indicate bearish trend continuation.

Price is making lower highs
RSI making higher highs
Indicating bearish continuation

Source: Tradingview.com

You can find many cheatsheets of RSI divergences online. Search for "RSI divergence overview" and you'll find a lot of examples. You can print these to learn the various types of divergences.

Rockwell Medical Inc Daily Relative Strength Index (RSI) Chart

3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

Leading momentum indicator, meaning the signals are instant.
Used to determine overbought and oversold areas much like the RSI.
Ranges between 0 and 100.
Above 80 is considered overbought.
Below 20 is considered oversold.
Consists of two lines named K and D.
K compares the highest high and lowest low on the selected price range.
The D line is a moving average of the K line.
Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Rockwell Medical Inc.

Rockwell Medical Inc Daily Stochastic Oscillator Chart

3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

Lagging or leading Momentum indicator
When the CCI is above zero, the price is above the historical average
When the CCI is below zero, the price is below the historical average
Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Rockwell Medical Inc.

Rockwell Medical Inc Daily Commodity Channel Index (CCI) Chart

3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

Lagging momentum indicator
Ranges between +100 and -100
Considered overbought above +50
Considered oversold below -50
It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Rockwell Medical Inc.

Rockwell Medical Inc Daily Chande Momentum Oscillator (CMO) Chart

3.5 Williams %R

Shows the current price relative to the highest high over the last 14 days.

Lagging momentum indicator
Ranging between 0 and -100
Above -20 is considered overbought
Below -80 is considered oversold
Is prone to give false signals

Score

Let's take a look at the Williams %R of Rockwell Medical Inc.

Rockwell Medical Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

Lagging volatility indicator
Uses 3 bands: one upper, one lower and one in the middle
Works best when the middle band reflects an intermediate trend (MA20).
When the price is moving closer to the upper band, the market might be overbought
When the price is moving closer to the lower band, the market might be oversold

Score

Let's take a look at the Bollinger Bands of Rockwell Medical Inc.

Rockwell Medical Inc Daily Bollinger Bands Chart

4.2 Average True Range (ATR)

Measures market volatility

Leading volatility indicator
Can be used to determine stop-loss positions
Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Rockwell Medical Inc.

Rockwell Medical Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Measures market volatility

Leading momentum indicator
Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
Can be used to confirm price trends
Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Rockwell Medical Inc.

Rockwell Medical Inc Daily On-Balance Volume (OBV) Chart

5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

Lagging momentum indicator
Looks like RSI but uses volume as an extra metric (RSI only considers price)
Above 80 is considered overbought
Below 20 is considered oversold
Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Rockwell Medical Inc.

Rockwell Medical Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Rockwell Medical Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

Date	Indicator	Signal
2023-12-05	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-06	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2023-12-08	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2023-12-12	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2023-12-13	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-14	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2023-12-15	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-19	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2023-12-20	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2023-12-22	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2023-12-27	STOCH	LONG EXIT		The %K line crosses below the %D line.
2023-12-28	MFI	LONG ENTRY	SHORT CLOSE	80 crossover to upside
2023-12-29	MFI	SHORT ENTRY	LONG CLOSE	80 crossover to downside
2024-01-03	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	ATR	SHORT ENTRY	LONG CLOSE	Price closed below (close - ATR).
2024-01-04	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-05	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-08	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-17	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-18	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
2024-01-19	STOCH	LONG EXIT		The %K line crosses below the %D line.
	MFI	SHORT ENTRY	LONG CLOSE	20 crossover to downside
2024-01-22	RSI	LONG ENTRY	SHORT CLOSE	30 crossover to upside
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	MFI	LONG ENTRY	SHORT CLOSE	20 crossover to upside
2024-01-24	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-01-25	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-29	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-01-30	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-01-31	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-02-01	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-02-02	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-09	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-02-12	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
2024-02-13	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-15	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-02-16	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-20	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-02-21	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-22	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-26	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-02-28	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-02-29	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-01	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-04	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-06	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-03-07	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-08	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-11	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
2024-03-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-13	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-03-14	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-03-15	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-03-20	MACD	LONG ENTRY	SHORT CLOSE	The MACD line crosses above the signal line.
	SAR	LONG ENTRY	SHORT CLOSE	The price broke the SAR to the upside.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CCI	LONG ENTRY	SHORT CLOSE	100 crossover to upside
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-21	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	WILLR	LONG ENTRY	SHORT CLOSE	-20 crossover to upside
	BB	SHORT ENTRY	LONG CLOSE	Price closed above the lower band.
	ATR	LONG ENTRY	SHORT CLOSE	Price closed above (close + ATR).
2024-03-26	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-03-27	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-02	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-04	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-05	STOCH	LONG EXIT		The %K line crosses below the %D line.
2024-04-09	MACD	SHORT ENTRY	LONG CLOSE	The MACD line crosses below the signal line.
2024-04-10	SAR	SHORT ENTRY	LONG CLOSE	The price broke the SAR to the downside
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
2024-04-11	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	CMO	LONG ENTRY	SHORT CLOSE	Zero line crossover to upside
2024-04-12	STOCH	LONG EXIT		The %K line crosses below the %D line.
	CMO	SHORT ENTRY	LONG CLOSE	Zero line crossover to downside
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-16	CCI	SHORT ENTRY	LONG CLOSE	-100 crossover to downside
2024-04-17	DMI	SHORT ENTRY	LONG CLOSE	The +DI crossed the -DI to the downside. The trend is reversing to a down trend.
	STOCH	SHORT EXIT		The %K line crosses above the %D line.
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-04-18	DMI	LONG ENTRY	SHORT CLOSE	The +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-19	STOCH	LONG EXIT		The %K line crosses below the %D line.
	BB	LONG ENTRY	SHORT CLOSE	Price closed below the lower band.
2024-04-22	STOCH	SHORT EXIT		The %K line crosses above the %D line.
2024-04-24	STOCH	LONG EXIT		The %K line crosses below the %D line.
	WILLR	SHORT ENTRY	LONG CLOSE	-80 crossover to downside
2024-04-25	STOCH	SHORT EXIT		The %K line crosses above the %D line.

6.3. Candlestick Patterns

Rockwell Medical Inc Daily Candlestick Chart

Date	Candlestick Pattern

6.4. Technical Score

Let's check the technical score of Rockwell Medical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

Indicator	Condition		Value
Open	Greater than	Close	1.480
Total			1/1 (100.0%)

Create your own Symbol Scanner

Get notifications about Rockwell Medical Inc

I send you an email if I find something interesting about Rockwell Medical Inc.

Rockwell Medical Inc Buy, Hold or Sell?

Let's analyse Rockwell Medical Inc together

Get notifications about Rockwell Medical Inc

Quick analysis of Rockwell Medical Inc (30 sec.)

What can you expect buying and holding a share of Rockwell Medical Inc? (30 sec.)

How much money do you get?

What is your share worth?

+ What do you gain per year?

For what price can you sell your share?

1. Valuation of Rockwell Medical Inc (5 min.)

$1.46

$0.73

$-0.81 - $11.03

$-0.09 - $11.76

2. Growth of Rockwell Medical Inc (5 min.)

Is Rockwell Medical Inc growing?

How much money is Rockwell Medical Inc making?

How much money comes from the company's main activities?

3. Financial Health of Rockwell Medical Inc (5 min.)

What can you expect buying and holding a share of Rockwell Medical Inc? (5 min.)

What can you expect buying and holding a share of Rockwell Medical Inc?

Speculation

Investing

How much money are you going to get?

When do you get the money?

How sure are you?

Linear %

Fundamentals of Rockwell Medical Inc

About Rockwell Medical Inc

Financial Health

Valuation

1.1. Profitability of Rockwell Medical Inc.

1.1. Profitability

1.1.1. Net Profit Margin

Trends

1.1.2. Return on Assets

Trends

1.1.3. Return on Equity

Trends

1.2. Operating Efficiency of Rockwell Medical Inc.

1.2. Operating Efficiency

1.2.1. Operating Margin

Trends

1.2.2. Operating Ratio

Trends

1.3. Liquidity of Rockwell Medical Inc.

1.3. Liquidity

1.3.1. Current Ratio

Trends

1.3.2. Quick Ratio

Trends

1.4. Solvency of Rockwell Medical Inc.

1.3. Liquidity

1.4.1. Debt to Asset Ratio

Trends

1.4.2. Debt to Equity Ratio

Trends

2. Market Valuation of Rockwell Medical Inc

2.1. Earnings Per Share

2.1. Price to Earnings Ratio

Trends

2.2. Price To Free Cash Flow Ratio

Trends

2. Book Value per Share

2.3. Price to Book Ratio

Trends

Rockwell Medical Inc
Buy, Hold or Sell?